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Abstract 
Stem cells from the hair follicle are an easily accessible population of cells that have a 
broad in vitro developmental capabilities and potential for autologous replacement of 
damaged adult tissue. The bulge region and follicle dermis play key roles in hair 
follicle development. Stem cells of the bulge region are of epithelial origin, whereas 
dermal components of the hair follicle are of mesenchymal origin. Here we have 
compared the characteristics of rat clonal stem cell lines derived from both the hair 
follicle dermal sheath and dermal papilla with rat bone marrow-derived primary 
mesenchymal stem cells. The cell types were compared in terms of their morphology, 
proliferation, expression of intracellular and cell surface antigens and differentiation 
. 
potential into bone and fat. The evidence presented here suggests that clonally 
derived stem cells from the follicle dermis posses some homologies with 
mesenchymal stem cells derived from bone marrow. Hence the hair follicle 
represents a potential niche for a mesenchymal-like population of stem cells. Both 
mesenchymal stem cells from bone marrow and stem cells from the follicle under 
specific in vitro conditions produce neural-like phenotypes. Here the two cell types 
were grown under conditions used in the culture of neural stem cells and formed 
aggregates that expressed the neural stem cell marker nestin. The effect of soluble 
factors produced by these aggregates on the development of neural progenitor cell 
populations was determined using aggregate conditioned media. The conditioned 
media induced process elaboration and differentiation towards the astrocytic lineage 
in a subpopulation of neural progenitors. Differential expression of antigens, loss of 
fat differentiation potential and extended proliferation capabilities were observed in the 
dermal clones. This aberrant behaviour could be attributable to transformation after 
extensive expansion in vitro, which has been demonstrated by their abnormal 
karyotype. 
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CHAPTER 1: LITERATURE REVIEW 
1.1 Introduction 
1. 1. 1 Definition of a stem cell 
Stem cells can be defined as clonogenic, self-renewing progenitor cells, that are able 
to generate progeny capable of producing one or more specialised cell types. 
Commitment of stem cells to specialised cell types (or differentiation) is produced by 
number of steps. The nature of these steps and the identities of the mature cell types 
formed depend on signals from the environment. In vertebrates stem cells can be 
divided into two groups; embryonic stem (ES) cells and adult stem cells (also referred 
to as organ- or tissue- specific stem cells). ES cells are derived from the inner cell 
mass of the early blastocyst and are pluripotent because they capable of producing all 
differentiated cell types in the body [1, 2]. Adult stem cells are derived from ES cells 
after gastrulation and persist into adult life. The most well characterised example of 
adult stem cells is the haematopoietic stem cell, which is multipotent and generates all 
the blood and immune system cell types. Other populations of adult stem cells that 
have been enriched but not in all cases definitively isolated include; mesenchymal 
stem cells, hair follicle stem cells, skin stem cells, corneal stem cells, neural stem cells 
(NSCs), and muscle (satellite) stem cells. 
1. 1. 2 Basic biology of adult stem cells 
Monitoring adult stem cell movement and division has shown that they normally divide 
slowly and that transit amplifying (TA) cells constitute to the vast majority of dividing 
cells in a tissue [3]. TA cells are not stem cells because they are committed to 
differentiate after a limited number of divisions and they often have a lower level of 
plasticity. TA cells in the brain, for example, only differentiate into one cell type 
whereas NSCs are bipotent, differentiating into both neurons and glia [4]. TA cells 
increase the efficiency that adult stem cells can maintain tissues, because they allow 
replacement of a large number of differentiated cells, whilst utilising only a limited 
stock of stem cells [5]. However, alternative paradigms to TA cells that maintain 
epidermal homeostasis have recently been suggested [6]. 
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Adult stem cells are the source cells that enable cellular renewal to take place and 
maintain adult tissues and organs as dynamic entities in a constant state of flux. The 
speed of renewal is highly variable between different adult stem cell populations. 
Stem cell populations in the brain turn over very slowly, whereas stem cells in the skin 
have a very rapid turn over. For example it is estimated that NSCs in adult mouse 
and rat brains produced only one neuron per day for every 2000 existing neurons in 
the brain [7]. Whereas keratinocytes, in samples of mouse epithelium, whose 
turnover was accurately estimated using "heavy" keratin (synthesized with 2H20), 
showed a much more rapid turnover. The epithelia reached full replacement after 
around three weeks in normal mice and four days in flaky skin mice [8]. It is 
speculated that different populations of adult stem cells are being activated to fulfil the 
reparative and maintenance functions of adult stem cells. Activation of dormant 
populations of multipotent adult stem cells may occur following tissue damage and 
unipotent stem cells for routine tissue renewal [5]. Adult stem cells serve to support 
and repair tissues and they have highly variable characteristics in terms of their 
proliferative and differentiation potential. 
Adult stem cells exist in a protected environment termed the niche that protects the 
stem cells from damage and maintains them in an undifferentiated state. Mammalian 
NSCs are maintained in their niche by the close proximity of blood vessels to the 
basal lamina. This close proximity enables the basal lamina to sequester the growth 
factors epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) from 
the blood vessels, which maintains the NSC population [4]. When needed adult stem 
cells proliferate and migrate from the niche and differentiate to form the cell type of the 
tissue in which they reside. The process of differentiation is very complex and 
controlled by a cocktail of molecules that activate molecular switches at specific times 
during development. Understanding what the molecules are, and the roles they play 
in controlling stem cell differentiation is a key question in stem biology. 
1. 1. 3 Adult stem cells: lineage-restricted or a greater differentiation repertoire? 
In the past decade an avalanche of work has been published that challenges the 
concept of lineage-restriction in adult stem cells [9]. These studies have proposed 
transitions form bone marrow to brain, skin to brain, bone marrow to liver, brain to 
heart and many more such unexpected feats of differentiation [1 0]. It was originally 
thought that adult stem cells produce a limited number of cell types, and have 
irreversibly lost the ability to produce cells that are developmentally unrelated in the 
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adult body. However, if the recent findings are entirely accurate then they would 
mean adult stem cells can reverse their lineage restrictions - perhaps by 
reprogramming gene expression - upon exposure to new environments (referred to 
as transdifferentiation). A second possibility is the notion of lineage restriction in adult 
stem cells is false, and there is little difference between adult stem cells and their 
embryonic counterparts [9, 11, 12]. 
Reprogramming of adult cell nuclei has been demonstrated in the past, with the 
ultimate example of this being the formation of ES cells from fully differentiated adult 
stem cells [13]. Reprogramming of nuclei resets the biological clock of a cell to its 
most primitive form. In doing so the adult cell - termed the "embryonic" adult stem 
cell is able to develop as if it were an ES cell. "Embryonic" adult stem cells are 
produced by transplanting the nucleus of an adult cell into an enucleated unfertilised 
egg. It has been demonstrated that reprogramming the nucleus of an adult cell is 
achieved by remodelling chromatin orgranisation using a cocktail of molecules. The 
first instance of nuclear reprogramming using nuclear transfer dates back to the late 
1950s using the model organism Xenopus Jaevis [14]. Here viable cloned embyos 
were created from nuclei taken from adult cells. More recently this was extended to 
the mammalian system when an adult ewe was cloned in the mid-1990s [13]. The 
event of nuclear reprogramming alone is not proof that adult stem cells are able to 
undergo transdifferentiation, because the cytoplasm that significantly defines the 
developmental status of the cell is artificially removed [9]. 
1. 1. 4 The focus of this review 
This review will focus on the basic biology, distribution and plasticity of two types of 
adult stem cells; hair follicle stem cells (HFSCs) and mesenchymal stem cells (MSCs). 
HFSCs principally reside in the bulge region of the hair follicle and contribute to the 
cyclical development of hair follicles [15]. Hair follicle development is initiated by the 
unique inductive properties of the hair follicle dermal papilla [16]. MSCs are 
multipotent stem cells showing adipocytic, chondrocytic and osteocytic differentiation 
potential [17]. MSCs are typically derived from bone marrow but have also been 
isolated from a number of other source tissues including the hair follicle [18, 19], 
which suggests a proportion of HFSCs could be represented by MSCs. MSCs and 
HFSCs are no exception to the emerging idea that adult stem cells may display 
surprising plasticity in their differentiation range. The notion of MSCs differentiating 
into cell types beyond their mesodermal germ layer is well established, through their 
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formation of cell types known to originate from ectoderm and endoderm germ layers 
[12, 20-24]. There is also growing evidence that the hair follicle is a potential source 
of stem cells capable of extraordinary differentiation potential beyond the confines of 
the hair follicle [11, 25-29]. This review will focus on the relationship between HFSCs 
and MSCs and the capabilities of these cells to produce neural lineages. Some 
researchers have been more sceptical about the notion of enhanced plasticity of adult 
stem cells and they have questioned the rigor of experimental methods used to 
demonstrate adult stem cell plasticity [30]. These findings will be reviewed with 
respect to MSCs and neural differentiation. 
1.2 Hair follicle Stem Cells 
1. 2. 1 Basic Biology of the hair follicle 
The hair follicle is a highly dynamic structure that forms during a process called 
morphogenesis and is subsequently cyclically renewed into post natal life by adult 
stem cells. In post natal life its development passes through three phases during one 
hair cycle; growth (anagen), regression (catagen) and rest (telogen). Hair follicles are 
formed by unique epithelial-mesenchymal signalling, which persists into adulthood 
[31]. A number of organisms have been used to study the adult hair follicle, which 
include mouse, rat, chicken and human. The rodent whisker (vibrissae) represents a 
good model for studying the hair follicle, because it is easily accessible and amenable 
to microdissection [28]. The post natal hair follicle is composed of a number of 
interconnected structures. These include the epithelial components and dermal 
components. Epithelial components consist of the bulge region, the bulb region, the 
shaft, the outer root sheath and the inner root sheath, whereas dermal components 
are the dermal papilla and dermal sheath. The dermal components and the bulge are 
the permanent structures of the hair follicle, while the other epithelial components 
appear at varying degrees of development depending on the stage of the hair cycle. 
1. 2. 2 Contribution of stem cells to post natal hair follicle development 
Populations of stem cells that contribute to hair follicle renewal are present in the 
bulge component of the hair follicle. Stem cells in the bulge region were originally 
suggested when it was noted that label retaining cells were restricted to the bulge 
region [15]. Early studies showed the differentiation potential and motility rate of 
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bulge stem cells was high as they were found in many areas of the hair follicle 
including the bulb region after transplantation [32]. 
A number of studies have attempted to label bulge stem cells, using several different 
techniques, to monitor their subsequent development and characteristics. The 
contribution of bulge stem cells to structures within the hair follicle has been monitored 
using 13-galactosidase labelling of transplanted LacZ positive bulge derived cells into 
athymic mice [32]. Bulge cells were labelled using green fluorescent protein (GFP) 
based on their slow cycling properties [33]. Other studies were able to express GFP 
in the bulge regions of transgenic mice by utilising the regulatory control element of 
the intermediate filament protein nestin [29, 34, 35]. Finally a double label consisting 
of bromodeoxyuridine (BrdU) and tritiated thymidine eH-thymidine) was used by [25] 
to track the movement and proliferation of stem cells originating from the upper 
follicle. 
An early study that monitored the progeny of transplanted bulge stem cells implanted 
bulge stem cells from transgenic mice constitutively expressing the reporter gene lacZ 
(Rosa26) into the bulge regions of whiskers (vibrassa) of athymic mice [32]. The lacZ 
positive bulge stem cells were tracked in the chimeric follicles using X-gal. Eight 
weeks after transplant intense blue X-gal positive bulge cells were located in all 
regions of the hair follicle including the bulb region, indicating bulge cells had migrated 
throughout the hair follicle and contributed to development of all but one of its 
structures. The only structure not positive for X-gal was the dermal papilla - this 
indicated it was not formed by stem cells from the bulge region and suggests a 
mesenchymal origin. Together these findings strongly indicate that the bulge region 
contains a highly motile and proliferative population of stem cells that are capable of 
differentiating into all structures of the hair follicle [32]. 
Bulge stem cells remained multipotent during migration to the end bulb. When 
keratinocytes reach the bulb region they stopped migrating and began to accumulate 
along the length of the follicle - shown by keratinocyte colony formation in all regions 
of the follicle. Once cells covered the length of the hair follicle and stopped migrating 
they differentiated into structures of the hair follicle depending on their position [32]. 
Hence, the length of anagen is dependent on the cessation of migration of bulge 
derived cells rather than an exhaustion of proliferative capacity and consequent 
shortage of progenitor cells, which has been suggested by others [36]. 
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The intermediate filament protein nestin was originally thought to label NSCs within 
the central nervous system (CNS). However, more recent findings have shown nestin 
is also expressed by progenitors within the hair follicle. Several studies were able to 
demonstrate nestin expression in follicle sections. Nestin expression has been 
reported in the inner root sheath, outer root sheath and bulge region of hair follicles 
isolated from human scalp tissue [37]. Importantly, nestin expression was not found 
in more mature structures such as the sebaceous gland and the hair shaft, indicating 
nestin exclusively marks progenitor cells. Based on these findings it could be 
hypothesized that nestin is downregulated in immature progenitor cells as they 
differentiate. Another study of human scalp tissue by showed nestin was expressed 
at the periphery of sebaceous glands, perhaps suggesting incomplete differentiation in 
these areas or variation between samples [38]. 
Nestin expression in hair follicle bulge regions has been used to label bulge derived 
stem cells by coupling its expression to GFP to create nestin-GFP cells in transgenic 
mice [34]. When the hair follicle progressed from telogen to anagen nestin-GFP cells 
proliferated and migrated out the bulge region to the outer root sheath. These cells 
occupied the upper portion of the hair follicle and were not present in the bulb region, 
which underwent terminal differentiation. In the catagen phase nestin-GFP cells 
declined in the outer root sheath until they could only be seen in the bulge region. 
Hence, nestin-GFP cells are direct progenitors of the inner root sheath, which may 
contribute to other structures within the hair follicle after nestin expression declines 
[34]. Bulge stem cells can also be marked with both 3H thymidine and BrdU using 
pulse chase, whereby after a long eight week chase period these labels are lost from 
faster cycling TAcells and retained by slow cycling bulge cells. BrdU labelled bulge 
stem cells have been tracked and found to migrate into the hair follicle similar to 
nestin expressing cells [25]. 
1.2.3 The signalling events leading to hair follicle morphogenesis in the 
embryo 
The hair follicle represents a unique model of reiterative epithielial-mesenchymal 
signalling events that lead to stem cell proliferation and differentiation. Early tissue 
recombination experiments elucidated the order of these signalling events [39]. The 
first signal in hair follicle morphogenesis arises from the dermis during 
embryogenesis, and causes regularly spaced thickenings in the epidermis referred to 
as placodes, which induce the formation of cellular clusters in the dermis called 
6 
dermal condensates [39]. Subsequent sequential signalling between the epidermis 
and the mesenchyme leads to the formation the dermal papilla from the dermal 
condensates and root sheaths and hair shafts from the placodes [40]. Hair follicle 
morphogenesis is regulated by a number of intercellular signalling molecules that 
activate signalling pathways, including Wnt and sonic hedgehog (Shh). 
Wnt is a strong candidate for the signalling pathway that initially conveys information 
regarding size and spacing of dermal appendages to the epidermis from the dermis 
during embryogenesis. The role of Wnts in hair follicle morphogenesis was confirmed 
through the expression of Dickkopf1 - a diffusible inhibitor of Wnt signalling - which 
caused a complete block on the formation of all dermal appendages including hair 
follicles. This indicated the Wnt pathway is at least required for the initiation of hair 
follicle morphogenesis [41 ]. Wnts are a family of extracellular ligands that signal by 
binding to frizzled receptors in a wide range of developmental situations. There are 
19 genes encoding Wnts and 1 0 encoding the frizzled receptor, which implies a wide 
variety of responses Wnts can elicit [42]. One response to a Wnt ligand binding to the 
frizzled receptor is a chain of downstream signalling events that result in the 
accumulation of nuclear 13-catenin (See [42] for a full explanation of the mechanism). 
13-catenin forms transcription inducing complexes with DNA binding factors from the 
lymphoid enhancer factor-1 (Lef-1) and T cell factor (Tcf) families, which induces the 
expression of many different target genes [40]. It is important to note that Wnt 
signalling is not simply an 'on' or 'off' switch for hair follicle morphogenesis, instead 
relative levels of interacting factors at specific times during development of the 
recipient cell dictates the effects of the signal [43]. 
The first dermal signal initiates a response in the epidermis that produces changes in 
gene expression, which result in placode and ultimately hair follicle formation. These 
changes are elicited by signalling molecules that both promote and repress hair follicle 
formation [40]. Wnt signalling is also induced in the epidermis by the dermis and 
promotes placode formation [44]. Fibroblast growth factors have a role alongside Wnt 
signalling in assisting placode formation, which has been demonstrated in developing 
chick placodes. [45]. The molecule ectodysplasin-A (EDA) and its receptor 
ectodysplasin-A receptor (EDAR) have been identified as essential for placode 
development based on mutant phenotypes observed in humans and mice [46]. 
However, variability in the hierarchy between Wnt and EDA/EDAR signalling in the 
epidermis in response to the first dermal signal has been reported in different 
organisms [41]. Bone morphogenic proteins (BMPs) and secreted BMP inhibitors 
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including Noggin, Follistatin, and Gremlin have a great influence on the epithelial 
response to the first dermal signal. BMPs are secreted signalling molecules that 
repress hair follicle formation and when they are themselves inhibited the formation of 
follicles is permitted. BMPs are expressed throughout the epithelium. Hence, the 
distribution of hair follicle placodes reflects the pattern of BMP inhibitor expression as 
they are present in developing hair follicles to nullify the effect of BMPs, and absent in 
interfollicular regions [40]. 
Hair follicle morphogenesis progresses through several other key signalling events 
between the dermis and epidermis after the formation of the epidermal placode. The 
first epidermal signal to the dermis is governed by Wnt and Shh signals, which 
initiates dermal condensate formation. Subsequently the second dermal signal is 
likely to be activated by Shh and causes epithelial proliferation and downgrowth. 
Finally formation of the hair shaft and inner root sheath are controlled by Notch and 
BMP signalling. For a detailed review of signalling events that lead to hair follicle 
morphogenesis see [40]. 
1. 2.4 Post natal signalling in hair follicle development 
Molecular analysis has revealed that the progression of post natal hair follicles 
through anagen, catagen and telogen, is thought to be governed by similar signalling 
pathways to those outlined for hair follicle morphogenesis. The first suggestion of 
homologies came when the new anagen phase was shown to be governed by 
signalling between dermal and epithelial follicular cells [47]. Some examples of 
characterised homologous signalling events in post natal hair follicles - between the 
dermis papilla and bulge region - that contribute to hair follicle development are 
outlined here. Wnt signalling is thought to play a pivotal role throughout hair follicle 
morphogenesis and is also prominent in post natal hair follicle development. Active 
Wnt signalling has been demonstrated in the bulge and dermal papilla of post natal 
hair follicles at the onset of anagen [33, 43, 48]. Further Wnt3a and Wnt7a have been 
shown to maintain the hair inducing properties of cultured dermal papilla cells, 
indicating the importance of Wnt signalling from the overlying epidermis in maintaining 
hair follicles in the anagen state [49]. The progression of slow cycling bulge stem 
cells to rapidly cycling TAcells in post natal hair follicles is influenced by Wnt 
signalling, because the activation of transcription in cell cycle genes c-Myc and cyclin 
01 is induced Lef-1 expression [42]. Like in morphogenesis the expression of 
secreted BMP inhibitors can activate epithelial stem cells in the bulge region and 
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induce anagen. The BMP inhibitor noggin overrides inhibition of the Wnt/~-catenin 
pathway by BMPs and enables hair follicle to progress into anagen [50]. These are 
just a small number of the numerous examples of homologies in signalling between 
morphogenesis and post natal hair follicle development. 
1.2.5 The extraordinary plasticity of HFSCs 
Bulge cells of the hair follicle have shown differentiation potential beyond hair follicle 
specific lineages. Experiments by Oshima et a/. (2001) indicated that bulge stem cells 
were able to differentiate into epithelial structures other than the hair follicle such as 
the interfollicular epidermis and the sebaceous gland. Nestin-GFP follicular bulge 
cells have been shown to migrate beyond the hair follicle and contribute to structures 
in its immediate vicinity. Indeed after transplantation nestin expressing bulge cells 
can form blood vessels which anastamose with existing blood vessels in both 
wounded and non-wounded skin [35]. Bulge cells have also been dual labelled with 
BrdU and periodic pulses of 3H thymidine to track their movement. Using this 
technique epidermal cells were found to proliferate much more slowly than follicular 
cells [25]. Intriguingly overtime the number of rapidly proliferating dual labelled cells in 
the follicle declined at a similar rate to an increase in rapidly proliferating cells in the 
epidermis. This demonstrated an emigration of progenitor cells from the hair follicle to 
the epidermis. Furthermore, in response to wounding a very similar emigration 
pattern was observed. These labelling studies strongly suggests that bulge derived 
stem cells produce proliferating progenitors that migrate and terminally differentiate 
into components of the hair follicle, blood vessels and cornified epithelial cells [25]. 
Finally potential neural differentiation has also been reported in the bulge region by a 
population of cells thought to be closely related to the neural crest [11, 51]. 
We have alluded to the notion of the hair follicle dermal papilla and the neighbouring 
dermal region the dermal sheath being a vital signalling centre that controls hair 
follicle cycling with its powerful inductive properties [49, 52]. However, until recently 
the dermal component of the hair follicle was not recognised as a source of adult stem 
cells with a differentiation repertoire beyond the confines of hair follicle specific 
lineages. Dermal stem cells that have shown mesenchymal potential have been 
isolated from the dermal papilla and dermal sheath components of the hair follicle [18, 
19]. Intriguing plasticity has been demonstrated by the reconstitution of the 
haematopoietic system of lethally irradiated recipient mice by transgenically marked 
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hair follicle dermal sheath and dermal papilla cells [26]. Hair follicle dermal cells have 
also been implicated in would healing [27] and neural differentiation [28, 53]. 
The precursor or precursors within the hair follicle dermis and bulge regions 
responsible for their unprecedented differentiation repertoire are largely 
uncharacterised. The only exception being the likely presence of a neural crest 
related progenitor to explain the neural cell differentiation, which will be reviewed 
more closely in the section 'In vitro neural differentiation of hair follicle stem cells'. 
Plasticity could be attributed to transdifferentiation of committed progenitors, dormant 
precursors of specific lineages or multipotent stem cells residing in the hair follicle. 
1.2.6 The mesenchymal properties of HFSCs 
Numerous locations have been suggested for MSCs - for a full review of these 
locations see the section 'Sources of MSCs'. The hair follicle represents a possible 
location for MSCs. A cloning strategy has been used to determine the in vitro fat and 
bone differentiation capabilities - already shown in primary explants - of progenitor 
cells derived from two hair follicle dermal cell populations [18]. A total of four dermal 
sheath clones (OS2, OS4, OS5 and OS7), and four dermal papilla clones (OP4, OP5, 
OP11 and OP12) were selected for potency testing based on their ability to efflux the 
dye Rhodamine 123, which had previously been used to identify stem cell populations 
in the pancreas [54]. Two of the clones tested (OP4 and OS5) were able to 
differentiate into fat and bone, four clones formed fat only (OS7, OP5, OP11 and 
OP12), one clone (OS2) formed bone only and one clone formed neither fat nor bone 
(OS4). Therefore it is clear from the potency analysis that cells residing in the dermal 
component of the hair follicle show a degree of mesenchymal potential. However, 
their relationship to MSCs is brought into question because the two clones that 
showed both bone and fat differentiation (OP4 and OS5) showed very low a-Smooth 
muscle actin (a-SMA) expression (a marker of MSCs), whereas another clone (OS7) 
showed a-SMA expression and differentiated towards the fat lineage only. These 
conflicting data show a lack of correlation between marker expression and 
differentiation potential of the clones. Interestingly cultured primary populations of 
follicle dermal papilla and dermal sheath show high levels of a-SMA expression [55], 
which suggests MSCs could be associated with these niches and that the cloning 
procedure may have caused a reduction in a-SMA expression. A second study also 
attempted cloning serial dilution from a heterogeneous population of human scalp-
derived adherent cells, which was isolated from hair follicle and interfollicular dermal 
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cells [56]. Both the cloned and primary cells showed the cell surface antigen profile of 
MSCs and differentiated into fat, cartilage and bone (see section 'Isolation and 
characterisation of MSCs'). It was noted that only 0.5 - 2% of isolated scalp cells 
adhered in the initial isolation, which indicated a low frequency of MSC-Iike cells in 
scalp tissue. In addition, unlike MSCs from other tissue sources these cells were 
dependent on EGF and bFGF for in vitro expansion [56]. Taken together these 
studies have used cloning techniques to reveal a potential niche for MSC-Iike cells in 
the hair follicle. The mesenchymal potential of primary cells isolated from the hair 
follicle dermis has been demonstrated by their differentiation towards fat, bone, 
cartilage and muscle lineages [19]. This reinforces the data from the dermal clones. 
Primary stem cell populations were also isolated from discrete sections of the hair 
follicle - including the bulge and dermal regions - and were differentiated towards 
both the bone and fat lineages, which indicates mesenchymal potential throughout the 
hair follicle [19]. 
1. 2. 7 In vitro neural differentiation of hair follicle stem cells 
The seminal paper which identified the skin dermis as a potential source of stem cells 
capable of differentiating into neural cell types was published by Toma and colleagues 
in 2001. Nestin positive spheres - termed skin-derived precursors (SKPs) - were 
isolated from both adult and juvenile mouse abdomen and back skin after mechanical 
dissociation, and cultured in conditions known to obtain NSCs from the brain. Serum 
free medium supplemented with EGF and bFGF induced the formation of SKPs in a 
small proportion of primary skin cells. After expansion the SKPs could be dissociated 
and plated on coated slides. Culture for seven days on these slides in the absence of 
growth factors induced a small proportion (less than 1 0%) of SKPs to differentiate 
towards neuronal, astrocytic and oligodendrocytic lineages [57]. Isolation of SKPs 
that differentiated towards neural lineages in a very similar fashion to mouse SKPs 
was also demonstrated in both adult and neonatal human dermis [57, 58]. 
Differentiation towards neural lineages of SKPs from all tissue types was 
demonstrated in clonally derived cultures, which illustrated plasticity of SKPs at a 
single cell level. A peripheral neuronal phenotype, in SKPs derived from neonatal 
human dermis, was confirmed using a larger panel of markers after differentiation in 
neurotrophin supplemented medium. Further the ability to expand these SKPs ex vivo 
for prolonged periods (greater than 15 months) whilst maintaining a normal karyotype 
was demonstrated [58]. More rigorous functional analysis of neuronal differentiation 
in SKPs was provided, when both fresh and culture expanded SKPs, were shown to 
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undergo changes in protein expression at time points that were indicative of a 
peripheral neuronal phenotype [59]. The peripheral neuronal phenotype was 
maintained in the CNS microenvironment, indicating a high degree of commitment. 
However, the differentiated SKPs did not form electrophysiologically active peripheral 
neurons as the cells did not posses voltage gated inward sodium currents [59]. 
Sphere forming dermal derived cells with similar properties to SKPs have been 
isolated from adult human skin by other investigators [60]. However, unlike SKPs 
these spheres were only expandable in vitro as an adherent monolayer in serum 
containing mitogen free medium. After expansion the cells could be induced to form 
spheres again that expressed nestin and were differentiated in hippocampal-
astrocyte-conditioned medium over a much shorter two day time course. Despite this 
shorter time neuronal proteins such as neuron-specific class Ill (3-tubulin (TuJ-1) were 
expressed in around 11% of cells, and perhaps more importantly the cells displayed 
some electrophysiological activity [60]. We have seen that dermal cells capable of 
rudimentary neural differentiation can be isolated from both rodent and human dermal 
tissues at different stages of development. The cells mimicked a time course of 
neuronal development based on protein expression patterns, but showed little 
evidence of producing fully functional neurons, which is a necessary property for 
these cells to be used in autologous transplantation. 
The identity of SKPs within the dermis has been determined by Fernandes and 
colleagues through further characterisation [28, 53]. They showed SKPs expressed 
the transcription factors slug, snail, twist, Pax3 and Sox9, which is an expression 
profile indicative of neural crest stem cells. SKPs also follow a migratory path of 
neural crest cells in ovo, as demonstrated by transplantation of yellow fluorescent 
protein positive (YFP+) SKP single spheres into a chick neural crest migratory system. 
Finally SKPs were found not to be derived from transdifferentiation of cell types 
formed from neural crest stem cells, namely melanocytes and Schwann cells. These 
pieces of evidence strongly support an undifferentiated neural crest identity of the 
precursor that has remained in the dermis since embryogenesis [28]. 
The markers that identified SKPs were used to single out a possible niche within the 
dermis for SKPs [28]. The key findings and conclusions from these data will be 
summarised here. Firstly in situ hybridisation on mouse back skin at various 
developmental stages, revealed expression of the neural crest markers expressed by 
SKPs, in the hair follicle dermal papilla. The dermal papilla location was confirmed by 
co-expression alongside neural crest markers of the dermal papilla markers versican 
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and nexin but not keratin 17 (a marker of the hair follicle bulge and outer root sheath). 
Further characterisation of embryonic and post natal whisker follicles provided 
additional evidence for a dermal papilla location of SKPs. Both embryonic and post 
natal vibrissae dermal papilla expressed neural crest markers in vivo, which are 
associated with cultured SKPs. SKP spheres derived directly from whisker dermal 
papilla also showed an expression and differentiation profile indicative of SKPs 
isolated from whole dermis. Importantly the presence of SKPs in the whisker dermal 
papilla was independent of other neural crest derivatives. A genetic method was used 
to permanently label cells with 13-galactosidase that expressed the neural crest marker 
Wnt-1 in vivo. Visualisation of labelled neural crest cells in mouse dermal papilla was 
achieved using the X-gal reaction, and provided further confirmation of the dermal 
papilla as a potential niche in the dermis for SKPs [28]. The same labelling technique 
has since been repeated on rat facial skin by others and neural crest derivatives were 
also found in the dermal papilla. Furthermore 25% of cells microdissected from the 
dermal papilla were able to form free floating spheres with a similar phenotype to 
SKPs after seeding single cells out, which represented a much higher conversion of 
cells to spheres compared to the whole hair follicle and dermis [53]. Taken together 
these data strongly suggest SKPs are of neural crest origin and reside in the dermal 
papilla of hair follicles of the rodent facial dermis. 
SKPs have also been isolated from the microdissected dermal papilla of human adult 
facial skin (53]. Successful isolation of these SKPs - referred to as papillaspheres -
was intriguing since a rapid decline in the frequency of SKPs isolated was shown in 
rats with aging. The neural crest origin of these papillaspheres was confirmed by the 
expression of the neural crest marker Sox1 0. These papillaspheres were nestin 
positive like SKPs, and formed neuronal and Schwann cell phenotypes, as shown by 
their morphology and protein expression profiles after differentiation. SKPs have also 
been isolated form the dermis of neonatal human foreskins [58], which do not have 
hair follicles, and therefore the niche for these SKPs cannot have been the dermal 
papilla. Isolation difficulties were encountered - in studies that used a similar protocol 
to SKPs - on whole human adult dermis from different hairless tissues, which either 
suggests that the extra-follicular neonatal SKP niche is restricted to the foreskin, or 
the niche becomes very rare in adult tissues [53]. Overall these findings are 
encouraging because they support data gathered from rodent facial skin and in doing 
so they further confirm the dermal papilla as a niche for SKPs. 
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Neural crest derived cells have been isolated from the bulge region of mouse facial 
skin [11 ]. Similar to neural crest derived cells from the dermal papilla these cells 
could be visualised based on their expression of the marker Wnt1. Sections of Wnt1-
cre/R26R compound transgenic mice skin showed neural crest derived cells located 
along the length of the follicle, indicating migration of these progenitors from the bulge 
region. The labelled cells could be explanted and differentiated towards neural crest 
derivatives both after cloning and at the population level. These lineages included 
glial fibrillary acidic protein (GFAP) positive Schwann cells and TuJ-1 positive neurons 
[11 ]. These neural crest derived cells were later shown to express a transcriptome 
that was distinct from other stem cell types in the bulge region [61]. However, neural 
crest derived cells could be related to nestin expressing cells from the bulge [29, 62]. 
Nestin expressing cells were isolated from the bulge region of previously discussed 
nestin-GFP mice and grown as spheres or colonies. The spheres showed 
differentiation potential of neural crest cells, migrated along pathways similar to neural 
crest cells after transplantation and expressed the neural crest transcription factors 
snail and twist. After in vitro differentiation the sphere derived cells expressed the 
neural lineage markers TuJ-1 and GFAP [62]. A second study, explanted cells from 
the bulge region and grew them for four weeks as colonies in serum free medium. 
After differentiation in serum containing medium for a further four weeks, the cells 
showed sequential differentiation towards the keratinocyte, astrocytic, neuronal, and 
smooth muscle lineages [29]. These data also strongly suggest that bulge stem cells 
show neural crest like characteristics. However, the expression of the epidermal stem 
cell marker CD34 and the marker K15 shows these bulge derived cells were not 
identical to cells of neural crest origin. 
Cells expressing nestin have been isolated from human scalp tissue, expanded as an 
adherent monolayer and differentiated towards neural lineages. However, these cells 
were not isolated specifically from the bulge region; instead they were isolated from 
samples of tissue that included whole hair follicles and interfollicular epidermis [38]. 
After expansion in culture nestin expression remained in 1 0-20% of adherent cells and 
they also acquired neuronal markers without the addition of differentiation factors to 
the medium. These neuronal phenotypes could be an artefact of the in vitro 
expansion conditions as they formed spontaneously in culture [38]. Another group 
isolated and expanded cells with neurogenic potential from whole human scalp tissue. 
These cells were specifically differentiated toward neuron-specific enolase (NSE) 
positive neuronal lineages in the majority of cases [56]. Together these two studies 
suggest there are cells within the human scalp that differentiate towards neuronal 
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lineages but they do not suggest a specific niche or cell identity like previous studies 
from facial skin. 
These data strongly suggest that cells isolated from the dermis of the rodent and 
human facial dermis are of neural crest origin and reside in the hair follicle dermal 
papilla. Neural differentiation was also found in cultured cells from within bulge region 
expressing the early neural stem cell marker nestin and the neural crest marker Wnt-
1. These data suggest that the bulge and dermal papilla stem cell populations in the 
hair follicle could be related through their homologies with neural crest cells and their 
propensity to differentiate towards neural lineages. 
1.2.8/n vivo neural differentiation of HFSCs 
There is a limited amount of in vivo evidence showing the capability of HFSCs to 
produce differentiated neural derivatives after transplant into the injured nervous 
system. However, the most prominent example of neural differentiation in vivo is 
SKPs, for which there is strong evidence of a hair follicle dermal papilla niche for 
these cells [28, 53]. Consistent with their relationship to neural crest cells, SKPs were 
shown to produce fully functional myelinating Schwann cells after transplant into the 
shiverer mouse mutant; a mouse unable to produce Schwann cell derived myelin 
basic protein (MBP) [63]. A purified population of YFP+ SKPs, which expressed the 
Schwann cell markers GFAP and p75 neurotrophin receptor in over 95% of cells after 
differentiation in neuroregulin-1 and forskolin, was produced in vitro. YFP+ purified 
Schwann cell differentiated SKPs and YFP+ undifferentiated SKPs were then 
transplanted into an injured peripheral sciatic nerve site in a shiverer mouse mutant 
and left for between six and eight weeks. SKPs at both developmental stages were 
able to form cells expressing the MBP antigen along the length of the injured sciatic 
nerve. lmmunoelectron microscopy revealed these MBP expressing cells represented 
genuine myelin architecture, indistinguishable from mature Schwann cells. MBP 
expression indicative of fully functional Schwann cells was also evident when SKPs 
were transplanted into the CNS of the shiverer mouse. These findings were also 
recapitulated in an in vitro coculture model. Together these data suggest that both 
peripheral damaged axons and CNS axons produce cues that cause na·ive and in 
vitro differentiated SKPs to differentiate into fully functional Schwann cells capable of 
producing myelin [63]. Cell fusion may be occurring and causing these phenotypes, 
but the frequency of. occurrence would not be high enough to explain the number of 
Schwann cells observed. 
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Nestin-GFP cells isolated from the bulge region as previously described, showed 
neuronal potential after they were transplanted into the subcutis of a nude mouse and 
expressed TuJ-1 after two weeks [29]. Schwann cell differentiation was also 
observed in cells expressing GFP that were isolated from the bulge region [64]. 
These cells were also cultured in vitro as colonies prior to transplantation, and their 
similarity to nestin-GFP bulge cells was confirmed by their expression of nestin and 
absence of CD34 expression. Schwann cell differentiation was produced when - like 
SKPs - the bulge derived cells were transplanted into a peripheral nervous system 
site close to a severed sciatic nerve. After two months live images showed GFP cells 
had localised around the repaired axon. Sections revealed GFAP expressing bulge 
cells had also closely surrounded the host axons with myelin sheath. Behavioural 
improvements were also apparent, with gastrocnemious contraction evident after 
electrical stimulation in injured mice that had bulge derived cells transplanted, but no 
contraction in those mice that were not administered a transplant [64]. These data 
strongly suggest that bulge derived stem cells are capable of enabling functional 
recovery by promoting and guiding axon development. A second study characterised 
the development of bulge derived cells that had been transplanted into a damaged 
mouse CNS site (the spinal cord) [51]. These bulge cells were marked by enhance 
enhanced GFP and their previously established neural crest phenotype was 
confirmed in vitro prior to transplant [11 ]. Enhanced GFP labelled cells were present 
around the injured spinal cord up to three months after transplant. Approximately half 
of the transplanted cells expressed the neuronal marker TuJ-1 and one third of cells 
expressed oligodendrocyte marker MBP. Host neurites were closely associated with 
bulge derived cells, suggesting the transplanted cells provided a microenvironment for 
regeneration. However, expression of GFAP was not reported in bulge cells 
transplanted into the spinal cord, unlike the sciatic nerve peripheral site, where GFAP 
was expressed [51]. Although neural differentiation was reported in the spinal cord, 
functional recovery after transplantation was not tested. From these data it is clear 
that bulge derived stem cells are capable of forming neural cell types in vivo, however, 
their fate is determined by the central and peripheral nervous system 
microenvironments into which they are administered. 
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1.3 MSCs 
1. 3. 1 Isolation and characterisation of MSCs 
MSCs are a multipotent adult stem cells population that can be induced to differentiate 
into adipocytic, chondrocytic, or osteocytic lineages [17]. MSCs were first isolated 
from mouse bone marrow, spleen, thymus and lymph node cells by Friedenstein et a/. 
in 1974. The cells were distinct from haematopoietic stem cells through their 
adherence to tissue culture ware and ability to form colonies 'capable of protracted 
self maintenance', hence they were initially referred to as fibroblast colony forming 
units (CFU-F) [65, 66]. In these early stages it was recognised that CFU-F were 
capable of contributing to the bone marrow and spleen microenvironment, and 
providing functional support for haematopoietic stem cells [67], but their differentiation 
ability had yet to be fully recognised. Since their isolation the developmental 
boundaries of MSCs is still a hotly debated topic being actively researched in stem 
cell Biology today. 
MSCs represent a scarce population in adult human bone marrow, typically 
contributing between 0.001% and 0.01% of the total cell number [17]. The most 
widely used technique to isolate the small proportion of MSCs from bone marrow 
utilises their adherence to tissue culture ware and subsequent ex vivo proliferative 
capabilities [65]. MSCs are isolated by aspiration of bone marrow onto tissue culture 
ware. The MSCs adhere whereas the contaminating non-adherent haematopoietic 
stem cells are removed by medium changes and passage. The resulting culture 
should consist of a heterogeneous population of MSCs at various stages of 
development. During ex vivo expansion the cells are constantly changing 
morphology. For example, it has been noted that there is a conversion - between 
early, small, spindle shaped, rapidly cycling progenitors and later, larger, mature 
progenitors that proliferate more slowly - as MSCs are expanded ex vivo [68]. 
Unlike haematopoietic stem cells there are no definitive phenotypic markers of MSCs. 
Instead a battery of cell surface adhesion and receptor markers and intracellular 
markers - not exclusive to MSCs - are used to illustrate the phenotype of the plastic 
adherent population. Common markers expressed by MSCs are the intracellular 
proteins a-SMA and vimentin alongside the extracellular matrix component fibronectin 
[69]. MSCs express cell surface markers known to interfere with haematopoietic stem 
cell proliferation and differentiation; these include CD9, CD29, CD44 and CD106 [70]. 
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Other cell adhesion and receptor molecules expressed by MSCs are CD54, CD55, 
CD73 (SH3 and SH4), CD90 (Thy-1), CD105 (SH2 or endoglin) and CD166 (ALCAM). 
MSCs coexist alongside haematopoietic stem cells in the bone marrow, and therefore 
their successful isolation is determined by the absence of haematopoietic stem cells. 
Hence they must be tested for the absence of haematopoietic stem cell markers 
CD11 b, CD34 and CD45 [17]. There are limitations with using these cell surface 
proteins to define MSCs as some groups report different expression patterns of 
specific proteins. Pittenger et a/. (1999) reported CD1 06 expression in human MSCs 
whereas others did not [71]. Variability in the proliferative stages of the MSCs could 
be responsible for the differences in expression patterns of antigens. For example 
CD34 negative MSCs have been shown to develop from a CD34 positive bone 
marrow fraction after prolonged ex vivo expansion [72]. Analysis of cell surface 
marker expression is a useful tool in characterisation of MSCs, but it is not definitive 
as none of the markers are specific to MSCs, and there are variations in their 
expression between studies. 
Attempts have been made to isolate a more homogeneous population of MSCs from 
bone marrow by fluorescent activated cell sorting, using a single phenotypic marker 
called STR0-1 , which identified clonogenic bone marrow derived progenitors able to 
form adipocytes, osteocytes and smooth muscle cells [73]. However it should be 
noted that STR0-1 + cells only represent 3 - 5% of the MSC population [70]. 
Furthermore, a method based on immunodepletion has been utilised in an attempt to 
fractionate haematopoietic cells from MSCs prior to culture. However these cells 
were compromised by the immunodepletion process as they proliferated very slowly 
[74]. Therefore without a definitive marker for MSCs the most effective way to isolate 
MSCs remains their ability to adhere to tissue culture ware. 
Marker analysis is a useful tool to characterise stem cell populations, however, it has 
limitations, including a lack of specificity to the stem cell population concerned. The 
gold standard used to define a multipotent adult stem cell is their capability to 
differentiate down several lineages. Hence, what defines MSCs as a multipotent stem 
cell is their ability to differentiate towards mesenchymal lineages. An in vivo example 
of mesenchymal differentiation, was when MSCs demonstrated their potential clinical 
application, through ostoegenic differentiation and the consequent repair of rat femurs 
after in vitro expansion [75]. Mesenchymal differentiation can also be achieved in 
vitro by adding inductive factors to the culture medium. The most prominent 
examples of this include: a) adipogenic (fat) differentiation where MSCs are treated 
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with dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), indomethacin and insulin; 
b) chondrogenic (cartilage) differentiation during which MSCs are induced with 
transforming growth factor-beta 1 (TGF-(31); c) osteogenic (bone) differentiation where 
MSCs are induced using a combination of dexamethasone, (3-glycerophosphate and 
ascorbic acid; d) Myogenic (muscle) differentiation where MSCs are induced using 5-
azacytidine, hydrocortisone and bFGF. There are numerous examples of these 
differentiation techniques in the literature and some degree of variability can be seen 
in the concentration of these factors and the time periods used for differentiation. It 
has also been noted in the case of fat differentiation that pharmacological stimuli such 
as IBMX and indomethacin may induce adipogenic phenotypes in cells non-reactive to 
physiological stimuli, and therefore interpretation of positive in vitro differentiation 
results should be treated with a degree of caution [17]. Histological assays are used 
to monitor differentiation into fat, cartilage and bone. The most common assays 
include; oil red 0 which monitors accumulation of intracellular lipid droplets after fat 
differentiation, Alcian blue stain which detects mucopolysaccharides after cartilage 
differentiation and Alizarin red or Von Kossa staining that detects a calcium rich 
mineralised matrix after bone differentiation. Further confirmation is provided in using 
immunological techniques for example detection of fatty acid binding protein 4 
(FABP4), aggrecan and ostoecalcin expression after fat, cartilage and bone 
differentiation. 
1.3.2 Sources of MSCs 
For the vast majority of studies MSCs have been isolated from the bone marrow of 
adult long bones such as femurs and tibias by aspiration. The condition called 
Osseous heteroplasia suggests MSCs could reside in tissues beyond bone marrow, 
because bone formation occurs within subcutaneous adipose tissues. This plasticity 
towards a mesenchymal lineage additional to fat suggests the existence of MSCs 
within adipose tissue [70]. It is now widely accepted that MSCs can be isolated from a 
variety of foetal and adult tissues. Adult tissues containing MSCs include peripheral 
blood [76], synovial membranes [77], pancreas [78], vibrissae follicles [19], exfoliated 
deciduous teeth [79], scalp [56] and adipose tissue [70]. Examples of foetal tissues 
containing MSCs include placenta [80], umbilical cord blood [81, 82], amniotic fluid 
[83], bone marrow, liver, lung and spleen [84]. Perhaps the most striking of findings 
was the residence of MSCs in most major organs of postnatal mice [85]. MSCs form 
these tissue have been comprehensively characterised in terms of their morphology, 
cell surface markers and mesenchymal differentiation potential. In doing so MSCs 
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from these tissue sources have been shown to have a high degree of homology to 
those isolated from bone marrow. Isolation of MSCs from tissues other than bone 
marrow again exploits their ability to adhere to tissue culture plastic. However, MSCs 
in the majority of other tissues are more difficult to isolate from their niche. 
Surrounding tissue must therefore be removed by mechanical mincing [19, 70, 80, 84] 
and by using enzymes such as collagenases [70, 77, 79, 85, 86] and trypsin [19, 80] 
to release the MSCs prior to ex vivo expansion. MSCs isolated from human 
pancreatic ducts were initially grown as free floating aggregates in medium 
supplemented with EGF and bFGF and adherent cells were able to grow out of these 
aggregates [78]. As discussed previously all MSCs isolated from tissues other then 
bone marrow were able to differentiate into at least two of the mesenchymal lineages 
previously discussed, with fat and bone being the most common lineages. 
Differentiation into lineages representing their tissue of origin as well as mesenchymal 
lineages was observed in pancreatic ductal epithelial cells, when they differentiated 
into beta cells expressing glucagon [78]. 
MSCs residing in a common perivascular niche throughout a wide range of adult 
tissues, would explain the paradox of the same cell type being isolated from a number 
of very different tissue sources. A perivascular niche for MSCs was alluded to in 
explanted dental pulp cells that showed mesenchymal potential through their 
differentiation into fat and bone. In vivo immunohistochemical staining showed dental 
pulp cells expressing the in vitro mesenchymal marker STR0-1 around blood vessels, 
which suggested a perivascular niche for this source of MSCs [79]. In addition a 
second study utilised STR0-1 to immunoselect dental pulp derived MSCs that 
showed a perivacular phenotype [87]. However, the marker STR0-1 is only specific 
to MSCs in an in vitro context and therefore could bind to non-mesenchymal cells in 
vivo, making it unreliable for analysing MSC distribution [85]. The contribution of 
MSCs to different tissue types has been monitored by marking cells and delivering 
them systemically [88]. Using this experimental approach would be limited in 
determining the niche of MSCs because the cells could engraft non-specifically to 
different tissues. The most successful approach so far that determined a perivascular 
niche for MSCs cantered around the successful isolation of MSCs from post natal 
vasculature and all major organs tested [85]. Their identity was verified by 
differentiating the cells into fat and bone and showing they expressed a-SMA. One of 
the blood vessels from which MSCs could be isolated was the kidney glomerulus, 
which compromised capillaries only. Hence MSCs could be isolated from the simplest 
of blood vessels. Taken together these results suggest MSCs reside in all post natal 
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organs by virtue of their perivascular location. However, variability existed between 
the cells form different locations in terms of their developmental capabilities. For 
example MSCs from the vena cava blood vessel showed significant bone formation 
and rudimentary fat differentiation, whereas muscle MSCs showed little bone 
formation and strong fat differentiation capabilities [85]. These developmental 
variations could be explained by MSCs being subjected to different environmental 
cues within their perivascular niche. 
1.3.3 Cloning as a tool to characterise bone marrow derived MSCs 
Cloning is a strategy which has been used assess the differentiation of MSCs -
isolated from a variety of tissues - into fat, cartilage and bone at a single cell level. 
Therefore cloning is a strategy which can be used to determine whether in vitro 
cultured MSC populations consist of a variety of progenitors committed to specific 
mesenchymal lineages or multipotent stem cells [85, 89, 90]. For example, cloning of 
MSCs was used as a strategy to determine if progenitors with proliferative and 
multipotent capacities were at least in part responsible for the phenotypes observed in 
explants from a number of adult tissues, including kidney, lung and muscle [85]. The 
successful isolation of these clones indicated a proportion of cells were committed to 
self renewal. Like their parent cultures the clones were able to differentiate into fat 
and bone. The proliferation and plasticity of these clones indicates a multi potent stem 
cell could be responsible for mesenchymal differentiation seen in a range of adult 
tissues [85]. Clones are generated using a technique called limiting or serial dilution, 
which involves seeding cells out at a density of one cell per well and expanding these 
cells to confluence. Hence the cloning process selects for cells from within a primary 
explant that have considerable proliferative capabilities, which is usually only a small 
proportion of the original population. This is highlighted by the vast majority of cloning 
attempts being unsuccessful with most single cells failing to divide sufficiently. For 
example, the successful isolation of hair follicle dermal sheath and dermal papilla 
clones in one study occurred in only 12-15% of cases [18]. 
In a study by Muraglia et a/. (2000) human bone marrow MSC clones were 
successfully isolated both with and without bFGF, and hierarchical model of 
differentiation of a single multipotent progenitor into fat, cartilage and bone was 
proposed. The model is based on data showing multipotent clones capable of 
differentiation into fat, cartilage and bone that progressively lost plasticity as the 
number of progenitor population doublings increased. These data suggested that the 
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fat lineage diverges and becomes independent at lower population doublings, 
whereas cartilage and finally bone lineages gain independence at higher population 
doublings. This evidence is supported by the fact all but one of the clones fell into just 
three potency categories; those showing fat-cartilage-bone differentiation, those 
capable of cartilage-bone differentiation and those capable of bone differentiation 
only, which indicates an ordered loss of plasticity symptomatic of the hierarchical 
differentiation model [89]. Furthermore, MSCs isolated from pancreatic ductal 
epithelium showed a similar divergence of the fat lineage before cartilage and bone as 
the cells were expanded ex vivo [78]. A study by Okamoto et a/. (2002) found 
plasticity in human MSC clones additional to the Muraglia group as clones were able 
to differentiate towards fat-bone, pure fat and pure cartilage lineages. Furthermore, 
the majority of clones were unable to differentiate down any of the three lineages. 
These data provided evidence against a hierarchical model for lineage commitment 
from a single multipotent progenitor, and suggested a random assortment of 
committed progenitors with variable degrees of plasticity within bone marrow. The 
apparent heterogeneity could, however, have resulted from the genetic manipulations 
required to immortalise the human MSC population from which the clones were 
isolated [90]. 
1.3.4 MSCs and HFSCs in the treatment of neurological diseases 
There are currently very few useful therapies for the treatment of neurological 
diseases. Difficulties have arisen in the treatment of these diseases through 
variations in pathologies between the different conditions. The administration of adult 
stem cells such as MSCs and HFSCs to treat neurological disorders represents a very 
exciting and genuine opportunity. HFSCs and MSCs have number of characteristics, 
which give them a lot of promise for the treatment of neurological disorders. The 
apparently high plasticity of HFSCs and MSCs, their ease of isolation and expansion, 
their potential for use in autologous transplantation and the circumvention of the 
ethical issues associated with the use of ES cells, all mean these adult stem cells 
have potential therapeutic applications in the treatment of neurodegenerative 
diseases. 
We have already seen the promise of HFSCs through their ability to differentiate 
towards neural lineages in vitro and produce functional Schwann cells after transplant 
into damaged nervous tissue. A wider ranging and far greater amount of research 
has investigated the potential use of MSCs in the treatment of neurodegenerative 
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diseases, which has produced much conflict and discussion. MSCs have been 
reported to induce varying degrees of functional recovery in many animal models of 
neurological disorders such as Huntington's disease, multiple sclerosis, Parkinson's 
disease and spinal cord injury [91-94]. Recovery of nervous system function was 
assessed using a range of techniques including behavioural tests and assessment of 
nerve regeneration. However, there are a number of questions which need to be 
addressed before MSCs and HFSCs can be used in the clinic for treatment of human 
neurological diseases. For example, should any attempt be made to purify 
populations of bone marrow or hair follicle primary explants prior to implantation? 
How should MSCs and HFSCs be administered, directly into the nervous system or 
systemically? At what time and at what frequency should MSCs and HFSCs be 
administered [95]? 
A much bigger issue for the use of MSCs in the treatment of neurological disorders, 
which must be overcome first, is the mechanism by which they elicit functional 
recovery after injury, which is a subject of great dispute. Three theories for 
contribution of MSCs to neural lineages have developed. It has been proposed that 
MSCs can form neural cells through direct differentiation stimulated by the 
extracellular environmental cues produced by cells already committed to the neural 
lineage or by a wide range of induction protocols. Another theory suggests MSCs can 
adopt neural lineage characteristics by fusing with existing neural progenitors. Finally 
it has been hypothesised that MSCs do not undergo differentiation themselves to elicit 
functional recovery; instead they manufacture soluble factors which mediate 
differentiation and repair of existing neural cells. 
1. 3. 5 Chemical induction of MSCs towards a neural lineage in vitro 
One of the seminal papers that induced MSCs toward neural lineages in vitro used 
neurotrophic factors that had been identified for NSC differentiation [22]. 
Differentiation conditions for NSCs were replicated by culturing MSCs for 7-14 days 
with medium containing 0.5~M retinoic acid (RA), 10% foetal calf serum (FCS) and 
brain derived neurotrophic factor (BDNF). Morphological transformations from flat 
fusiform to spindle shaped cells, and the up regulation of the neural markers lead to 
conclusions of neural differentiation in MSCs. However, the neural differentiation of 
MSCs was only evident in a small proportion (0.2%) of cells, which suggested the 
heterogeneous MSC population either contained a very low frequency of multipotent 
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progenitors or contained a small proportion of cells capable of being reprogrammed 
towards neural lineages upon culture in vitro. 
A considerably larger frequency of MSCs developed neural progenitor phenotypes 
based on morphological and protein expression profile, after induction for 6 days with 
the phosphodiesterase inhibitor IBMX and the a cyclic adenosine monophosphate 
(cAMP) analogue dbcAMP [23]. It was proposed that the increase in intracellular 
cAMP concentration caused by this treatment, decreased proliferation and increased 
process extension, which induced a neural-like phenotype. This differentiation was 
not reversible because removal of IBMX and dbcAMP caused neural-like cells to die 
within a number of days. A second chemical treatment, which caused differentiation 
of MSCs into progenitors resembling neural cells was caused by culture of high 
passage MSCs in serum free medium containing dimethyl sulfoxide (DMSO) and 
butylated hydroxyanisole (BHA) [21]. This protocol produced the most neural-like 
cells with 75% of induced cells showing neuronal morphologies. These chemical 
induction protocols produced very high yields of cells displaying neuronal-like 
phenotypes compared to neurotrophic factor driven induction. 
Several neuronal markers were also used after chemical induction to confirm the 
neural phenotypes. Western blot data have shown the neural markers TuJ-1 and 
NeuN were expressed both before and after MSCs were induced, which suggests 
MSCs already have some characteristics of the neural lineage. Furthermore, GFAP 
expression has been shown to be completely absent, indicating changes to growth 
medium do not induce expression of some neural proteins [21, 23]. This is perhaps 
due to MSCs being driven away from the glial lineage and towards a neuronal lineage 
under certain induction conditions [96]. Commitment to the neuronal lineage was 
confirmed by the early neuronal marker NSE, which had seemingly dramatically 
increased its expression levels after treatment with the chemicals IBMX and dbcAMP 
[23]. These NSE data verify the findings of a previous study, where an increase NSE 
expression was observed alongside the acquisition of morphological neuronal 
phenotypes under DMSO/BHA chemical induction conditions [21]. This marker 
analysis indicates commitment towards a neural lineage by MSCs upon chemical 
induction. 
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1.3.6 Summary of early neural induction protocols in MSCs 
We have seen that chemical induction protocols such as treatment with 
IBMX/dbcAMP and DMSO/BHA are able to induce a very large number of neural-like 
phenotypes, whereas treatment with neurotrophic factors induce similar phenotypes in 
a much smaller proportion of cells. Furthermore cocultures of MSCs with neural cell 
types can also be used to effectively induce neural-like phenotypes. Finally, gene 
transfection with notch intracellular domain (NICD) or noggin has also been used to 
specifically produce neuronal-like phenotypes in MSCs [97, 98]. There are many 
other very similar examples of in vitro MSC neural induction in the literature, which 
use simple induction protocols that have slight variations on those outlined here. 
1. 3. 7 Re-evaluation of early in vitro neural differentiation protocols 
Recently pioneering work by Woodbury and co-workers that showed in vitro MSC 
differentiation into neural-like phenotypes has been more thoroughly examined [21 ]. 
The analyses from several independent studies present strong evidence that neural 
differentiation is a potential artefact of the in vitro culture conditions, and not true 
neural differentiation, which was originally suggested. Serum withdrawal and 
treatment with the chemicals BHA and DMSO demonstrated the appearance of 
neural-like MSCs in a very short time period of just five hours [21], whereas NSCs 
usually take several weeks to differentiate [99]. The rapidity of neural phenotype 
development casts serious doubts on the validity of this early study, and was the 
premise for further investigation. Time-lapse video revealed the morphological 
changes that produced pseudo neuronal and glial phenotypes actually resulted in a 
reduction of cell area, after treatment with serum free medium supplemented with the 
chemicals DMSO/BHA [100-102]. Cytoplasm retraction was caused by disassembly 
of focal adhesion sites, and filopodium-like extensions appeared as a result of strong 
paxillin positive focal adhesion sites that remained along thin transects of the 
cytoplasm [1 02]. These morphological changes are atypical of neural development, 
which is produced by active neurite outgrowth after induction, rather than the 
differential rates of cytoplasm retraction observed here. Further investigations into 
changes to the cytoskeletal architecture involved in neuron-like differentiation, 
revealed disruption of the actin cytoskeleton was the primary mechanism through 
which neuron-like morphologies were acquired in vitro by MSCs [1 00-1 02]. Selective 
disruption of the F-Actin cytoskeleton using the drug cytochalasin B, caused 
morphological and protein expression profile changes very similar to those produced 
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when MSCs were cultured in response to serum withdrawal and DMSO/BHA chemical 
treatment. These changes were also reversible, which is not thought to be typical of 
cells undergoing lineage commitment. The ability to very closely mimic neural-like 
development induced by DMSO/BHA treatment using a technique that induces 
cytoskeletal changes completely unrelated to neural development, questions the 
validity of chemical induction. 
A reduction in cell area following induction lead to the suggestion that a concomitant 
increase in NSE and neural morphological change, was due to an increase in antigen 
expression per unit area rather than a true increase in protein expression. As 
previously described MSCs express a number of neural antigens including NSE at low 
levels prior to induction; therefore a concentrating effect due to a reduced cell area 
after induction, which mimics an increase in antigen expression, seems conceivable. 
Also, the non-neural marker aSMA showed a similar increase in expression after 
DMSO/BHA induction, which was likely to have been caused by a similar mechanism. 
The pseudo increase in NSE expression was demonstrated elegantly when the same 
'increases' in expression after chemical induction were shown in MSCs that had 
protein expression completely abolished prior to treatment. Therefore observed 
expression could not have been due to increases in transcription and translation of the 
NSE protein after induction, which would be required for true differentiation [1 03]. 
Furthermore, microarray analysis of the whole transcriptome of MSCs after treatment 
with DMSO/BHA revealed very little change in gene expression, whereas huge 
differences in gene expression between untreated MSCs and NSCs were observed. 
These data confirm that large scale changes in gene expression are required for 
neural differentiation, which do not occur after DMSO/BHA chemical induction [1 00]. 
Treatment of MSCs with DMSO has caused an increase in expression at the protein 
level of the neural stem cell marker nestin and the neuronal antigen NeuroD1, which 
indicates these antigens are up regulated at the transcriptional and translational level. 
The increases were shown by Western blot and therefore could not have been due to 
the concentration of existing proteins. However, the increased expression of nestin 
and NeuroD1 proved to be linked to signalling pathways activated as a result of 
cytoskeleton disruption associated with DMSO treatment, and were therefore 
independent of neural differentiation [101]. Together these data show phenotypic 
changes caused by DMSO/BHA chemical induction are a result of mechanisms not 
associated with neural development. 
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There are some uncertainties regarding the specificity and correct applications of 
some of the markers that have been used to indicate neural differentiation after 
chemical induction. For example, nestin is used to show neural progenitor 
commitment but is also expressed in skeletal muscle development [1 04]. Expression 
of the early neuronal marker TuJ-1 has been shown in many human tissues, therefore 
its use in studying human MSC neural development is limited [1 00]. The antigens 
NeuN and Tau have been used to demonstrate neural development but their 
distribution was not typical of neurites. After chemical differentiation both NeuN and 
Tau were distributed throughout the cytoplasm but NeuN expression should have 
been concentrated around the nucleus and Tau should have localised along the 
pseudo neurites. Therefore the distribution of NeuN and Tau actually provides 
evidence against true neural differentiation [1 00]. These observations show caution 
should be taken when analysing data based upon expression of a limited number of 
neural protein markers. 
The reviewed studies provide a very comprehensive argument against claims that 
phenotypic changes observed in vitro after chemical treatment with DMSO/BHA 
represent commitment to the neural lineage. However, they do not completely rule 
out the possibility that MSCs differentiate towards neural lineages using different 
protocols. Another theory suggests the plasticity of MSCs can be accounted for by a 
rare pluripotent population of cells that exists within the bone marrow [12]. These 
cells were termed multipotent adult progenitor cells (MAPCs). The existence of 
MAPCs could explain why a very low proportion of MSCs were able to differentiate 
into neural lineages after treatment with BDNF and RA [22]. Also an increase in 
Nesitn positive MSCs capable of forming neural lineages [1 05] could be explained by 
an increase in the proportion of MAPCs in the culture after extensive passage. The 
pluipotency of MAPCs was demonstrated when they were differentiated into cells of 
the visceral mesoderm, neuroectoderm and endoderm at the single cell level. Human 
mesodermal progenitor cells have been isolated using the same low density culture 
technique that was used for the isolation of MAPCs [1 06]. MAPCs could be expanded 
in culture without differentiation. A high proliferation potential was demonstrated in 
MAPCs because telomere length remained stable for 40 population doublings. 
Furthermore, MAPCs differentiated into all three germ layers both in vitro and in vivo, 
which illustrated similarities with ES cells. However, some dissimilarity with ES cells 
does exist. For example, proliferation non-purified cultured MSCs is induced by EGF, 
whereas ES cells require human leukaemia inhibitory factor (hLIF) to induce 
proliferation. Propensity of MAPCs towards a mature neuronal lineage was 
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demonstrated by expression of the neuronal marker MAP-2 as well as the absence of 
the astrocytic marker S100 and the oligodendrocyte marker MBP. 
It must still be cautioned that up regulation of neural markers in response to simple 
changes to growth medium in vitro does not provide enough evidence that sub-
populations of MSCs are capable of forming mature fully functional neurons, 
displaying electrophysiological activity indicative of the neural lineage. Furthermore, 
the variation in stimuli used to induce neural morphologies, the diversity of starting 
populations and discrepancies in passage number prior to induction complicates 
comparison of in vitro neural differentiation studies. These additional factors lead to 
further uncertainties surrounding the in vitro neural differentiation capabilities of 
MSCs. 
1. 3. 8 Production of neural phenotypes by MSCs in vivo 
A number of early in vivo studies imply transplanted MSCs have differentiation 
capabilities beyond the mesenchymal lineage and also form cells from the neural 
lineage [107-109]. The majority of studies made some attempt to purify MSCs from 
bone marrow and expanded them ex vivo prior to transplantation. An exception was 
the transplantation of a mixed population of bone marrow into mice. The 
haemaotpoetic contingent either differentiated into other cells types or died because 
the hematopoetic antigen CD45+ was downregulated post transplantation [11 0]. 
There are other significant variations in experimental approach across in vivo studies 
showing neural phenotypes. MSCs have been marked using a variety of methods 
including GFP and the nuclear labels BrdU and bis-bezimide [1 08, 109, 111]. 
Implantation of MSCs uses a variety of techniques. A systemic approach, involves 
introducing MSCs into the circulatory system and allowing them to migrate and engraft 
into the brain [112], whereas other groups have directly injected MSCs into specific 
areas of the brain [1 07]. The condition and age of the recipient's nervous system has 
great variation. Some studies involve neonatal recipients, whereas others use adult 
recipients [107, 109]. There are examples of transplantation of MSCs into fully 
functioning nervous tissue [1 07, 1 09], whereas in other studies the nervous tissue was 
damaged [1 08]. Early studies reveal there are significant variations in the 
experimental approach used to analyse the activity of transplanted MSCs in vivo, 
which makes interpreting and analysing the data difficult. However, a variety of 
experimental approaches will ultimately allow determination of the best ways to 
implant MSCs into the nervous system. 
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Commitment of MSCs towards a neural-like lineage in vivo was often based on the 
coexpression of neural markers in labelled MSCs. For example, the differentiation of 
MSCs after transplantation into cerebral infarct mice was validated through the 
expression of neuronal markers NeuN and MAP2 [1 08]. However, after 
transplantation of MSCs into the injured spinal cord GFAP was expressed, which 
indicated glial differentiation. Furthermore, glial-like differentiation was also shown by 
GFAP positive MSCs that had engrafted into the hippocampus of non-infarct mice 
[1 09]. From this it can be concluded that differentiation of MSCs into glial and 
neuronal phenotypes was determined by the specific microenvironment the nervous 
tissue provided. Others alluded to the loss of mesodermal identity in MSCs as an 
indicator of neural differentiation when MSCs were implanted into rat brains [1 07]. 
The investigators in these studies deem that MSCs are beginning differentiation into 
functional neuronal and glial cells upon implantation into the nervous system using a 
number of different approaches. However, the simple expression of a limited array of 
markers in vivo is not sufficient evidence to validate this theory and more vigorous 
analysis needs to be considered. For example it needs to be assessed if MSCs are 
differentiating into functional neurons that express a number of mature neural 
markers, and have electrophysological activity similar too mature neural cells. 
1. 3. 9 Cell fusion is a possible explanation for neural phenotypes 
Cell fusion was predicted in MSCs when spontaneous fusion events involving other 
stem cell types were observed in vitro [113, 114]. Cell fusion events were first 
detected between cocultured R26R MSCs expressing a Cre dependent LacZ reporter 
gene and Cre + brain multi potent progenitor cells [115]. A fusion event caused 
activation of the Cre dependent LacZ reporter gene in MSCs by the Cre + brain 
progenitors. LacZ activation and therefore fusion events between MSCs and brain 
progenitors were visualised using X-gal. After four days a small proportion of cells -
one to two per 80 0000 cells - were positive for X-gal. Dual nuclei were confirmed in 
the stained MSCs by electron microscopy. The supernumeracy of nuclei was lost 
through mitosis, which was illustrated using BrdU. Fusion of MSCs with neurons and 
other cell types was also detected in vivo, which resulted in the formation of 
multinucleated cells in some cases. This was demonstrated in the mouse cerebellum 
using electron microscopy, which showed fused cells displaying purkinje neuron 
morphologies that had two distinct nuclei. The frequency of cell fusion events showed 
great variability between recipient mice, indicating fusion is likely to be controlled by a 
29 
number of variables. This study indicates cell fusion with existing progenitors is a 
possible mechanism controlling reprogramming of nuclei in MSCs. However, the low 
frequency of fusion is unable to account for every neural like cell derived from 
transplanted MSCs, therefore other mechanisms - such as reprogramming without 
fusion - must be at large to account for these phenotypes. 
Additonal studies have also advocated cell fusion between MSCs labelled with GFP 
and purkinje neurons [116, 117]. The GFP+ cells had undergone cell fusion in lethally 
irradiated mice, and had comparable morphological features to purkinje neurons, such 
as complex dendritic trees and axons. In addition to previous studies the fusion event 
here was shown to reprogram the nuclei of MSCs. The initially compact nuclei of 
MSCs became increasingly dispersed with time. To investigate whether these distinct 
changes to chromatin morphology lead to reprogramming of the MSC nucleus, a 
purkinje specific promoter termed L7 was linked to GFP expression in the bone 
marrow derived cells. The L7-GFP construct was activated after bone marrow was 
transplanted into the host, which was shown by GFP+ purkinje neurons. GFP 
expression definitively proved that host prukinje neurons were causing expression of a 
pukinje specific gene in MSCs after a fusion event. These data demonstrate a 
mechanism by which cell fusion between MSCs and host neural cells can lead to 
changes in the protein expression profile that accompany morphological alterations. 
However, no attempt to purify MSCs was made before implantation, which means 
contaminating haematopoietic stem cells may have contributed to some of the fusion 
events in this study. Administering MSCs after lethal irradiation could have altered 
cell membrane properties through genomic modifications, which would favour fusion 
events. Therefore it is possible the experimental set up was increasing the frequency 
of fusion events above what would normally be seen [1 05]. Even with the possibility 
of enhanced cell fusion, the frequency of fusion events was still very low after 
monitoring for more than a year. Hence it is clearly possible that populations of MSCs 
can undergo cell fusion and produce neural phenotypes. However other experimental 
techniques are needed to verify cell fusion is in fact occurring because there are some 
doubts surrounding the use of irradiated cells. 
It is possible that neural differentiation of MSCs in vivo could be dictated by signals 
provided by microenvironments within the brain and not cell fusion. A large number of 
MSCs were found to be participating in neural differentiation in vivo, which cannot be 
all be accounted for by the low frequency of cell fusion. However, it may be possible 
for MSCs that have undergone phenotypic changes resulting from cell fusion to 
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appear as non fused cells with neural phenotypes, by continuing to divide after 
reprogramming from a fusion event has occurred [115]. Division after fusion could 
therefore explain the discrepancy between the frequencies of fusion events and the 
appearance of neural phenotypes in vivo. However, a group has demonstrated the 
appearance of a high proportion of neural-like cells upon in vitro coculture in the 
absence of cell fusion. 
Cell to cell interactions - perhaps mediated by soluble factors - between nestin 
positive MSCs and mature neural cells are thought to be influential in causing neural 
differentiation in MSCs independent of cell fusion events [1 05]. Nestin expression 
was induced in high passage MSCs after transfer to serum free medium. The 
coculture of these rat nestin positive MSCs with GFP+ mouse NSCs produced a high 
proportion of MSCs showing neural differentiation. GFP- cells coexpressed the neural 
antigens GFAP and TuJ-1 indicating neural differentiation of MSCs in the absence of 
cell fusion with GFP+ NSCs. Cell fusion was definitively ruled out by the mouse 
astrocytic antibody (M2) as well as and mouse neuronal antibody (M6) exclusively 
binding to GFP+ NSCs. These antibodies exclusively binding to GFP+ cells also ruled 
out downregulation of GFP causing NSCs to appear as MSCs. Furthermore, this 
study demonstrated that neuronal MSCs were capable of firing action potentials and 
responding to the glutamate neurotransmitters. Importantly the currents were 
abolished by tetrodotoxin (TTX), which indicates these action potentials were caused 
by voltage-activated sodium channels, which is symptomatic of neuronal cells. The 
expression of nestin prior to coculture was also shown to be essential for the 
formation of neurons. Nestin positive MSCs were thought to have heightened 
sensitivity to neuronal cues from NSCs through expression of intracellular factors 
important in nervous system development [1 05]. 
The imposed coculture conditions do not show that MSCs have all the electrical 
characteristics of fully mature neurons. This either means there is something missing 
in the experimental set up preventing MSCs forming mature neural derivatives, or that 
the phenotypic characteristics are an artefact and MSCs are incapable of forming 
neural derivatives. An explanation of the primitive neuronal phenotype seen could be 
that undifferentiated MSCs harbour some electrophysiological properties and ion 
channel expression [118]. These data indicate MSC plasticity without cell fusion could 
be responsible for the differentiation of MSCs into neural-like cells. However, the 
characterisation of differentiated progeny based on surface marker expression and 
inconclusive electrophysiological data, is not satisfactory to fully justify direct 
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differentiation of MSCs into fully functional neural phenotypes in the absence of cell 
fusion. 
1. 3. 10 MSCs provided trophic support to existing NSCs 
Repair of infarct areas of the brain can be measured using the neurological severity 
score (NSS) behavioural test. One explanation for the improvements in NSS is that 
the expression of neural markers by MSCs illustrates their differentiation into 
functional neural cells, which are entirely responsible for the recovery seen. However, 
coexpression evidence alone is insufficient to suggest MSCs were causing 
improvements by differentiating directly into neural cell types themselves. The time 
taken for large scale neural functional recovery to occur is far too short for MSCs to 
differentiate into fully functional neural cells with all their associated connections. 
Furthermore we have seen that early claims of MSCs differentiating toward neural 
lineages in vitro must be treated with great caution and that some of the neural 
phenotypes in vivo could be accounted for by rare cell fusion events. Therefore it has 
been hypothesised that MSCs provide support through secretion of soluble factors to 
existing NSC populations. 
It has been proposed that the production of trophic factors and cytokines by MSCs 
after transplantation could be responsible for recovery after damage to nervous tissue 
resulting from a middle cerebral artery occlusion (MCAO) [119]. A supporting function 
for MSCs in renewal of neural tissues was suggested because MSCs were able to 
respond to different ionic microenvironments by adjusting growth factor production. It 
is therefore possible that the degree of tissue injury and corresponding alteration of 
the ionic environment determines secretion of trophic factors by MSCs, which in turn 
ameliorate existing nervous tissue [119]. Convincing evidence has been put forward, 
which shows MSCs contribute to functional recovery through production of soluble 
factors. After intravenous administration, MSCs initially migrated to the ischemic 
boundary zone (IBZ) in rats and apoptosis detection revealed they subsequently 
decreased levels of apoptosis in the existing neural cells within the IBZ compared to 
controls animals [120]. In vitro findings demonstrated MSCs are able to secrete 
factors such as BDNF and nerve growth factor (NGF), which could account for the 
reduction in apoptosis seen in vivo as well as proliferation and differentiation of 
endogenous neural stem and progenitor cells. Furthermore, signalling pathways 
contributing to increased survival of existing neural cells are upregulated following 
treatment of neural cells that have undergone anaerobic insult with MSCs [121]. Two 
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signalling pathways known to strongly influence cell survival called phosphoinositide 
3-kinase/threonine protein kinase (PI3k/Akt) and mitogen-activated protein kinase 
kinase/extracellular signal-regulated kinase (MEK/Erk1/2) were examined. MSCs 
were cocultured in vitro with post-ischemic astrocytes and found to enhance both 
survival pathways in post-ischemic astrocytes after 18 hours. Real time polymerase 
chain reaction (RT-PCR) also showed growth factors such as BDNF and bFGF 
showed a considerable expression increases in ischemic astrocytes after coculture 
with MSCs [121]. Hence after coculture MSCs have been shown to have both 
protective and possibly inductive effects on post-ischemic astrocyte populations. 
Amelioration of existing neural tissue was later demonstrated in vivo when MSCs 
were transplanted 24 hours after MCAO using a number of methods [122]. There are 
several phenotypic effects which demonstrated amelioration of damaged neural tissue 
after administration of MSCs. These included angiogenesis, synaptogenesis and 
differentiation of existing neural progenitors. Angiogenesis was shown by an increase 
in vascular perimeter and density in the cortical penumbra. Synaptogenesis was 
demonstrated post stroke by a significant increase in synaptophysin expression, 28 
days after MSCs were transplanted. Increased synaptogenesis suggests MSCs 
induce axon remodelling in the cortex and therefore improve functional outcome in the 
damage brain. Lastly MSCs significantly increased the frequency and optical density 
of NG2 positive cells in the brain cortex. NG2 signifies the presence of 
oligodendrocyte progenitor cells, which enable neuroprotection by stimulating repair 
mechanisms in response to brain injury. Hence these data highlight the mechanisms 
by which MSCs can contribute to functional recovery of damaged neural tissue in vivo 
after MCAO by affecting the development of existing neural cell populations. Similar 
results have been produced by treatment of other models of neurodegenerative 
diseases with MSCs, such as the intravenous treatment of mice suffering from an 
animal model of multiple sclerosis [94]. Together these findings show how MSCs 
enable improvements after loss of neurological function in vivo, by inducing repair 
mechanisms in the host nervous system through the production of a variety of 
molecules. 
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1.4 Conclusions & perspective for future work 
1.4. 1 Potential niches for MSCs and cloning 
In this review we have seen that there are potentially many sources of MSCs. A 
common perivascular niche could explain the widespread distribution of MSCs [85]. 
One of the common strategies used to characterise adult stem cells, which has been 
used in many situations is using clones. Cloning strategies have been used to 
propose the opposing hierarchical and committed progenitor models for bone marrow 
MSC development towards mesenchymal lineages [89, 90]. Mesenchymal 
differentiation reflective of parent cultures has been demonstrated using a cloning 
strategy in MSCs from tissue sources other than bone marrow [77, 80, 85]. Cloning 
has also been used to demonstrate neural and mesenchymal developmental potential 
representative of parent cultures in the hair follicle [18, 28]. 
1.4.21s the hair follicle dermis a niche for bone marrow derived MSCs? 
The cloning strategy used to characterise the dermal niche for MSCs will be continued 
here in this study [18]. A sample of two clones (termed DS7 and DP9) from the hair 
follicle dermis will be further characterised and compared to bone marrow MSCs, 
which are a more established source of MSCs. This first part of the study will 
determine any similarities between the two cell types and help suggest if the hair 
follicle dermis could be a potential niche for bone marrow MSCs. By comparing a 
cloned population of adult stem cells with a primary population the analysis may also 
reveal disadvantages of using an in vitro cloning strategy to compare phenotypes. 
1.4.3 Potential contributions of MSCs and HFSCs to neural development 
The discoveries showing MSCs and HFSCs are capable of forming neural lineages 
and contributing to recovery upon implantation into the mammalian nervous system, 
has huge implications for the application of these two cell types in stem cell biology 
and in the treatment of neurological disorders. However, before these two cell types 
can be used safely in the treatment of neurodegenerative disorders such as 
Parkinson's disease and strokes the mechanisms for differentiation and amelioration 
of existing neural cells must be more comprehensively evaluated. 
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Plasticity of MSCs and HFSCs cannot be ruled out because a huge number of studies 
have demonstrated neural like differentiation. In the case of MSCs the importance of 
rigorous characterisation has been demonstrated by recent studies showing that 
pioneering in vitro neural differentiation observations were in fact produced by the 
removal of MSCs from their physiological environment and subsequent exposure to 
chemical stress rather than authentic neural differentiation. Hence, in vitro neural 
differentiation protocols may have unexpected, misleading effects and must be treated 
with caution. Perhaps the most likely explanation for adult stem cell plasticity is the 
presence of multipotent precursors that have remained in the two tissues from 
embryogenesis into adulthood. These are referred to as MAPCs [12] from bone 
marrow and neural crest related cells from the hair follicle dermal papilla and bulge 
region [11, 28]. We have seen that these neural crest related cells can elicit recovery 
in vivo after sciatic nerve injury and in mouse Shiverer mutants. These findings are 
due to differentiation of hair derived cells into Schwann cells, which are neural crest 
derivatives. However, both cell types do not show full neural differentiation 
capabilities in vitro. For example neither of the two cell types showed the 
electrophysiological activity of mature neurons after differentiation into neuronal cell 
types in vitro. This illustrates aberrant expression of neural proteins and 
morphologies in vitro is either an artifact of cell culture or that induction protocols 
towards neural lineages are not sophisticated enough to induce fully functional neural 
cell types. Therefore, a more thorough examination of the molecular signalling events 
leading to differentiation is necessary to verify the ability of MSCs and HFSCs to form 
neural lineages. 
Cell fusion is a possible explanation for the in vivo plasticity of MSCs and HFSCs after 
transplantation into the peripheral and CNS. However, in the case of HFSCs the 
frequency of cell fusion is too low to explain the quantity of cells showing a Schwann 
cell phenotype [63, 64]. For MSCs also cell fusion is unlikely to be the only 
mechanism to explain the neural phenotypes observed because its frequency is too 
low. A more likely explanation for the role of MSCs in causing neural recovery is by 
promoting endogenous repair of the CNS by secreting cytokines and growth factors. 
To date promotion of endogenous repair by the secretion of soluble factors is the most 
convincing explanation, because it provides a link between MSC implantation and 
gain of neural function, which cell fusion and plasticity fail to demonstrate. The 
production of soluble factors that stimulate endogenous repair is a phenomenon which 
is likely to extend beyond MSCs to other adult stem cell types including HFSCs 
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1. 4.4 Using conditioned media to investigate the effects of MSC secreted 
factors on neural development 
A useful in vitro tool, which helps understand soluble factor mediated signalling 
between populations of adult stem cells and NSCs, uses MSC conditioned medium 
(MSC-CM). MSC-CM has been generated in vitro by culturing MSCs at different 
stages of development in defined media and then removing the media from the cells 
after one to three days. During this time defined media will have been 'conditioned' 
with secreted soluble factors from the MSCs. The effect of these soluble factors in 
MSC-CM has been tested on NSC populations to ascertain if it has any effects on 
their development. 
MSC-CM has been shown to promote survival of neuronal cell types after induction of 
neuronal injury. Dopamine neurons from the ventral mesencepalon of rat embryos 
were subjected to injury using both serum deprivation and treatment with a neurotoxin 
[123]. MSC-CM was generated by culturing an undifferentiated confluent monolayer 
of MSCs for 24 hours with serum free N2 medium. The medium was found to both 
reduce loss of tyrosine hydroxylase (TH) positive neurons after exposure to 6-
hydroxydopamine neurotoxin, and enhance expression of TuJ-1 and TH in the 
neurons compared to serum free medium controls [123]. Another study by lsele and 
co-workers (2007) found MSC-CM - harvested from confluent undifferentiated MSCs 
after 18-20 hours - attenuated apoptosis, which was induced in embryonic rat 
neurons five hours after MSC-CM was added [124]. The concentration of conditioned 
media was found to be very important, with 40% conditioned medium protecting 
stressed cells the most successfully and 1 00% solutions causing adverse effects. 
This result highlights the concentration of secreted factors produced by MSCs is vital 
in the effectiveness of treatment and great caution needs to be used if MSCs are to 
have therapeutic applications for neurological disorders. The MSC-CM was found to 
stimulate pathways involved in neuronal survival, because by blocking these 
pathways the beneficial effect of MSCs was lost. Double MSC-CM was also created 
by conditioning medium with MSC soluble factors that had already been conditioned 
with factors secreted by stressed neurons. Interestingly the double conditioned 
medium had a more potent protective effect, indicating a cross talk between MSCs 
and stressed neurons that causes an enhanced neurotrophic effect [124]. This 
evidence supports previous work, which indicates MSCs secrete neurotrophic factors 
such as bFGF and NGF after exposure to extracts of injured brain tissue. 
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A study by Rivera et a/. (2006) identified that MSe-eM was able to instruct adult 
NSes to form Gale• oligodendrocytes at the expense of GFAP+ astrocytic 
differentiation [125]. Standard serum containing expansion medium was cultured with 
undifferentiated MSes for three days to create MSe-eM, which was used to culture 
adult NSes for seven days. Once it was established that significantly more Gale• and 
significantly less GFAP+ NSes were present in samples treated with MSe-eM 
compared to the control, it was determined if the oligodendrocyte phenotype was due 
to selection or induction by MSe-eM. Selection of Gale• NSes by MSe-eM could 
have been either through an increase in proliferation (determined by BrdU 
incorporation) or a decrease in the death (determined by propidium iodide - PI -
incorporation) of subpopulations of cells expressing a specific antigen. There were no 
significant differences in BrdU or PI incorporation in subpopulations of NSes labelling 
for specific antigens when MSe-eM was compared to the control. Therefore through 
this analysis it was found the oligodendrocyte fate of NSes was independent of 
selective mechanisms, and was likely to be an instructive effect on an uncommitted 
precursor by MSe-eM. Instruction was confirmed by a significant increase in 
expression of the oligodendrocyte transcription factors and down regulation of 
oligodendrocyte inhibitors compared to controls of NSes treated with MSe-eM [125]. 
The developmental status of MSes has a profound influence on the composition of 
MSe-eM, which has been shown to select an astrocytic phenotype in mouse 
embryonic NSes [126]. In the previously outlined studies MSe-eM has been derived 
from undifferentiated MSes, whereas Wislet-Gendebien and co-workers took 
conditioned medium from MSes induced to express nestin. Nestin positive MSes 
conditioned serum free medium for three days. For comparison MSe-eM was 
collected from MSes not induced to express nestin by serum removal. A significant 
increase in astrocytic (GFAP+) and concomitant decrease in oligodendrocytic (04+) 
and neuronal (TuJ-1+) differentiation was found in NSes treated with conditioned 
medium from nestin positive MSes, compared to nestin negative MSes and the 
control. BrdU incorporation showed MSe-eM - from nestin positive MSes - was not 
causing a significant change in the proliferation of any specific NSe subpopulations. 
However PI incorporation showed that after two days culture, nestin positive MSe-eM 
significantly reduced cell death in the GFAP positive subpopulation, compared to the 
control and nestin negative MSe-eM. No such reductions in cell death were found in 
any other subpopulation. The investigators next found using Western blot that nestin 
positive MSe-eM had high levels of the active BMP4, whereas nestin negative MSe-
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CM contained the inactive form. Further, the protective effect of nestin positive MSC-
CM on the GFAP+ subpopulation was negated when the conditioned medium was 
treated with an anti-BMP4 antibody [126]. These data strongly suggest that MSCs 
induced to express nestin secrete an active form of BMP4, which selectively protects 
astrocyte populations of NSCs, and does not instruct the astrocytic phenotype. 
The four reviewed studies have shown that MSC-CM can be used to characterise the 
protective, inductive and selective effects MSC-derived soluble factors can have on 
various NSC populations, which supports previous data suggesting MSCs are able to 
secrete factors that mediate endogenous repair. 
1.4.5 What effect do soluble factors in conditioned media from adult stem cells 
have on NSC development? 
In vivo studies have shown neural antigen positive MSCs are capable of causing 
significant recovery after systemic injection into brain-lesioned mice. These 
improvements cannot be attributed to MSCs directly differentiating into neural cell 
types, because the proportion of cells expressing neural antigens is not high enough 
to cause such significant recovery [127]. An alternative explanation could be the 
upregulation of neural antigens in transplanted MSCs causes them to secrete soluble 
factors that mobilise large numbers of endogenous NSCs, which facilitate recovery 
from injury. We have already seen using MSC-CM that the secretion of soluble 
factors by MSCs induced to express the neural stem cell antigen nestin facilitates 
survival of NSC subpopulations [126]. This in vitro study supports the theory that 
neural antigen expression in MSCs is a prerequisite for their influence on NSC 
development. However, there is a paucity of information on the effect of soluble 
factors produced from adult stem cell populations induced to express neural antigens 
in vitro, using techniques that more closely replicate the development of NSCs in vivo. 
It is established that adult hair follicle dermal cells and MSCs can be induced to form 
neurosphere-like aggregates that express neural antigens [53, 128]. Therefore the 
second aim of this study is to induce hair follicle dermal stem cells and MSCs to form 
neurosphere-like aggregates, and see what effect the soluble factors these 
aggregates produce have on the development of NSCs using aggregate conditioned 
media. 
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CHAPTER 2: Materia~s and Methods 
2.1 Isolation and maintenance of cells 
2. 1. 1 The isolation MSCs from rat postnatal bone marrow 
To isolate rat MSCs (rMSCs) an established procedure was used with adaptation 
[129]. The rMSCs were extracted from the bone marrow of 6-8 month old Wistar rats 
that had been euthanised using C02. The femurs and tibias were removed from the 
rat, cleaned of all muscle and connective tissue, sprayed with ethanol and placed in 
collection medium, which consisted of RPMI-1640 (Invitrogen) supplemented with 
10% FCS (Invitrogen), 20 units/ml Penicillin-Streptomycin (Invitrogen), 1x non-
essential amino acids (Invitrogen) and 2mM L-Giutamine (Cambrex). Under sterile 
conditions the bones were removed from the collection medium and one of the ends 
was clipped, exposing the medullary canal containing the bone marrow. Using a 21-
gauge needle filled with 1Om I of fresh collection medium the marrow was aspirated 
out of the bone into a 60mm Petri dish (Nunc). The flushing process was repeated 
using the same medium to maximise the yield of bone marrow from each bone. The 
aspirate was then transferred from the Petri dish to a 75cm2 culture flask (Nunc) with 
an additional 1Om I of fresh collection medium. Subsequently the cells were cultured 
in the collection medium at 37°C and 5% C02 for two days to allow the stromal cells to 
adhere to the tissue culture plastic. After this time the non-adherent contaminating 
haematopoietic cells were removed and the adherent cells were washed using 
complete culture medium (CCM) - consisting of Dulbecco's modified eagle's medium 
(DMEM; Sigma-Aldrich) supplemented with 10% FCS, 20 units/ml Penicillin-
Streptomycin, 1 x non-essential amino acids and 2mM L-Giutamine. Fresh CCM was 
added to the washed adherent cells. Every three days the medium was replaced with 
fresh CCM until the cells were 90% confluent, which usually took one week depending 
on the initial yield. A 90% confluent 75cm2 flask of adherent cells was defined as 
passage zero (PO). 
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2. 1.2 Passage of MSCs 
To passage rMSC the CCM was removed, the cells were washed with phosphate 
buffered saline (PBS; Cambrex) without Mg2+ and Ca2+ and then detached by 
incubation with 2.5ml of 0.25% trypsin and 0.1% versene at 36°C for two minutes. 
The trypsin was inactivated by adding 7.5ml of CCM and the cells were spun at 250 X 
g for 5 minutes. The trypsin and medium were removed and the pellet was 
resuspended by gentle trituration in 1 ml of CCM. For optimum expansion the cells 
were seeded at 10 000 cells/cm2 into 20m I of fresh CCM in 75cm2 tissue culture 
flasks. Using this procedure a single PO 75cm2 flask produced three 75cm2 tissue 
culture flasks of P1 MSCs. For subsequent routine expansion to higher passages the 
same procedure was used. 
2.1.3 The preparation of hair follicle dermal clones 
Both the hair follicle dermal cell clones DS7 and DP9 were kindly provided by 
Professor Colin Jahoda. The procedure used to isolate these cells has been 
previously described [18]. Briefly, primary dermal papilla and dermal sheath cells 
were mircrodissected from 3-month-old female Wistar rat vibrissae follicles. Dermal 
papilla and dermal sheath primary explants were maintained in 24 well plates using 
culture medium consisting of minimum essential medium (MEM; Sigma-Aldrich) 
containing 10% FCS and Gentamycin (50 mg/ml; Invitrogen) plus 20% dermal papilla 
or dermal sheath primary culture conditioned medium. Primary cultures were 
incubated at 37°C and 5% C02 for five days. In this time cell growth from the explants 
was evident with limited cell division. Cells were collected from each individual 
explant by detachment using 0.25% trypsin and 0.1% versene incubated for five 
minutes at 37°C. The primary cells were cloned by limiting dilution in 96 well plates 
(Nunc) at a density of one cell per well. After 24 hours wells with single cells were 
identified using a phase contrast microscope. These wells were cultured in the 
medium used for primary explants for 28 days with a medium replacement every 
seven days. The two clones were transferred to 35mm wells (Nunc) and medium was 
changed every three to four days over a period of 16 - 35 additional days at 37°C and 
5% C02. Once confluency was reached, the clones were transferred into larger 12.5 
cm2 tissue culture flasks (Nunc) and expanded for 10 - 14 more days in MEM 
supplemented with 10% FCS. 
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2. 1.4 Routine maintenance of clones 
The two dermal clones (087 and OP9) were routinely maintained in 75cm2 tissue 
culture flasks at 37°C and 5% C02, in the CCM used for the expansion of primary 
rMSCs with a medium change every three days. Each clone was passaged when 
confluent every three to six days. To passage the CCM was removed and the same 
trypsinisation procedure was followed as that used for the primary rM8Cs. The clones 
were seeded in 75cm2 tissue culture flasks containing 20ml of CCM at a density of 36 
000 cells/cm2 for the 087 clone and 29 000 cells/cm2 for the OP9 clone respectively. 
For all experiments the passage number of the clones ranged from P20 to (P41 ). 
2.2 Characterisation of cells 
2.2.1 Chromosome counting and karyotype analysis 
Karyotype data for the two dermal clones 087 and OP9 was kindly provided by 
Professor Colin Jahoda. The chromosome counting and karyotype analysis for the 
rM8Cs was performed by Chrombios GmbH following the same procedures used for 
the dermal clones. Prior to the analysis the chromosomes had to be prepared. To 
ensure the rM8Cs were growing exponentially they were routinely passaged into 
75cm2 tissue culture flasks at a density of 10 000 cells/cm2 and cultured for two days. 
After this time colcemid (Invitrogen) was added to the culture medium at a 
concentration of 0.2~g/ml and incubated at 36°C for two hours. The rM8Cs were 
trypsinised, spun at 200 X g in a 15ml tube for ten minutes and all but O.Sml of the 
resulting supernatant was removed. The pellet was resuspended by gently flicking 
the tube and 1Om I of hypotonic solution - comprising 75mM KCI (Fisher) in water -
was added drop wise with continual agitation of the tube. The cells were left for ten 
minutes in the hypotonic solution, subsequently spun at 200 X g for 10 minutes and all 
but O.Sml of the resulting supernatant was removed. The pellet was then 
resuspended by gentle flicking and 3m I of fixative - comprising a 3: 1 mixture of 
methanol (Fisher) and acetic acid (Fisher) stored at -20°C - was added drop wise 
whilst gently flicking the tube. The tube was then filled up with a further 12ml of 
fixative and left for 30 minutes at -20°C. The fixed cells were spun at 270 X g for ten 
minutes and they were resuspended by gentle flicking in O.Sml of supernatant. The 
tube was filled drop wise with 15ml of fixative and the cells were transported in a 
chilled box. 
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All work done after the fixing process was completed by Chrombios GmbH. The cells 
were analysed by chromosome counting and karyotype analysis. Approximately 30 
rMSC metaphases were imaged, three metaphases were karyotyped in detail, and 
chromosomes were counted for 15 metaphases. To give good chromosome 
spreading 401-JI of the fixed cell suspension was dropped onto a slide, incubated at 
60°C for one hour, stained with 4'-6-Diamidino-2-phenylindole (DAPI) and mounted in 
an antifade solution. The slides were processed using a Zeiss Axioplan II 
fluorescence microscope attached to a b/w CCD camera and images were taken 
using SmartCapture VP software. Metaphase cells were imaged, printed and 15 sets 
of metaphase chromosomes were counted. To karyotype the cells Quips image 
processing software for reverse DAPI banding was utilised. 
2.2.21mmunocytochemistry: Intracellular antigens 
The rMSCs and the dermal clones DS7 and DP9 were seeded at a density of 20 000 
cells/cm2 on sterilised glass cover slips in 12 well plates (nunc) and incubated for 24 
hours in DMEM supplemented with 10% FCS. The medium was removed and the 
cells were washed for five minutes in PBS. The cells were then fixed for 15 - 20 
minutes in cold 4% paraformaldehyde (PFA; Sigma-Aldrich) dissolved in PBS. To 
make the 4% PFA PBS was heated, PFA was dissolved in it, and the solution was 
filtered on ice immediately. Cells were then blocked for one hour in blocking solution 
consisting of 1% goat serum (Invitrogen), 1% Albumin from bovine serum (BSA; 
Sigma-Aldrich), 0.5% Triton-X-1 00 (Fisher), 0.1% sodium azide (Sigma-Aldrich) 
dissolved in PBS. The cells were incubated with the primary antibodies in staining 
solution - consisting of 1% goat serum, 1% BSA, 0.2% Triton-X-1 00, 0.1% sodium 
azide dissolved in PBS at pH 7 - for one hour at room temperature. The following 
intracellular antigens were tested; nestin (Chemicon; 1 :200), GFAP (Sigma-Aldrich; 
1 :200), TuJ-1 (Covance; 1 :600), fibronectin (Sigma-Aldrich; 1 :200), a-SMA (Sigma-
Aldrich; 1 :400) and vimentin (Sigma-Aldrich 1 :400). Cells were then washed three 
times for five minutes in blocking solution to remove any unbound primary antibody. 
The cells were incubated protected from light for 45 minutes in the appropriate anti-
mouse (Sigma-Aldrich; 1:1 00) or anti-rabbit (Sigma-Aldrich; 1:1 00) lgG (secondary 
antibodies) conjugated to fluorescein isothiocyanate (FITC). A control for each cell 
type using secondary antibody only was tested alongside those wells initially 
incubated with primary antibodies. Any unbound secondary antibody was removed by 
washing the cells three times for five minutes in PBS. The cover slips were then 
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removed from the 12 well plates, mounted on microscope slides using Hoechst 33342 
(Invitrogen; 1:1 000) in vectorshield (Invitrogen) ready for imaging. 
2.2.3 Versican immunohistochemistry and immunocytochemistry 
Early anagen rat vibrissae follicles were used as a positive control for veriscan 
expression. The follicles were embedded in OCT embedding medium (RA Lamb) and 
cut in to several 71Jm sections using a cryostat. The sections were mounted on 
histobond slides (RA Lamb) and stored at -20°C. The rMSCs and the dermal clones 
DS7 and DP9 were seeded at a density of 20 000 cells/cm2 on sterilised glass cover 
slips in 12 well plates and incubated for 24 hours in CCM. The sectioned vibrissae 
follicles were dried for 30 minutes and all three cell types growing on glass cover slips 
were removed from the CCM and washed in PBS prior to fixing. The samples were 
fixed in 100% methanol at -20°C for 10 minutes followed immediately by 100% 
acetone (Fisher) for five minutes at -20°. The fixative was removed using three five 
minute washes of PBS. Versican antibody (Developmental Studies Hybridoma Bank) 
was applied undiluted to the samples for one hour at room temperature and was 
removed. Following three five minute washes of PBS, the samples were incubated for 
1 hour in anti-mouse secondary antibody conjugated to FITC. The secondary 
antibody was taken off and unbound antibody was removed by washing three times 
for five minutes in PBS. The vibrissae follicles were mounted ready for imaging using 
Hoechst 33342 (1:1000) in PBS, whereas the three cell types on the glass cover slips 
were mounted on microscope slides using Hoechst 33342 (1: 1 000) in vectorshield. 
2.2.4 Analysis of cell surface antigen expression using flow cytometry 
Flow cytometry was used to analyse the expression of haematopoietic and 
mesenchymal cell surface antigens on both rMSCs and the dermal clones DS7 and 
DP9. All cell types were cultured in 75cm2 tissue culture flasks in CCM and at 
confluency the medium was removed, the cells were washed with PBS and then 
trypsinised. A single cell suspension was produced by triturating the cells in PBS; the 
cells were washed with a further 9ml of PBS and spun at 250 X g for five minutes. 
The cells were fixed overnight at 4°C by resuspension in 0.25% PFA. The fixative 
was removed, the pellet was resuspended in wash buffer - consisting of 0.1% BSA 
and 0.1% sodium azide dissolved in PBS at pH 7 - and cell number was determined 
using a haemocytometer. For each antigen tested a 2001JI volume of wash buffer 
containing 800 000 cells as a single cell suspension was dispensed into a 15ml tube 
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(VWR). All tubes were spun at 250 X g, the supernatant was removed, and the cells 
were resuspended with 501JI of primary antibody at the appropriate working dilution. 
Cell suspensions were incubated for one hour on ice. The following primary 
antibodies and primary antibody working dilutions were used: CD34 (Chemicon; 1: 15), 
CD45 (Becton Dickinson; 1: 15), CD90 (Becton Dickinson; 1: 15), CD44 (abeam; 1 :50), 
CD105 (santa cruz biotechnology; 1 :50) and a negative control P3X (Professor Peter 
Andrews, University of Sheffield; 1 :50). All antibodies had reactivity to rat and the 
working dilutions were created using wash buffer. After incubation the primary 
antibody was removed with three washes in 1501JI of wash buffer. The cells were 
incubated protected from light on ice for 45 minutes in 501JI of the appropriate anti-
mouse ( 1:1 00) or anti-goat (Sigma-Aldrich; 1:1 00) secondary antibodies conjugated to 
FITC. Secondary antibodies were subsequently removed with three washes of 1501JI 
of wash buffer and the cells were transferred to FACS tubes (BD Biosciences). 10 
000 cells from each sample were passed through a FACS Calibur flow cytometer (BD 
Biosciences) with fluorescence measured on a logarithmic scale. Cytometric traces 
were analysed for each of the antigens using CeiiQuest Pro software. Thresholds that 
determined the frequency of positive cells were set using the P3X negative control 
(with the appropriate secondary antibody), before levels of tested cell surface antigens 
were analysed. 
2.2.5 Proliferation assay 
Proliferation of rMSCs was compared to proliferation of the dermal clones DS7 and 
DP9 using an established procedure with adaptation [18]. The three cell types were 
plated at an initially density of 30 000 cells per well in 24 well plates (Nunc) and 
counted at days one, two, three, five, seven, nine and 11. At each time point the 
medium was removed from three wells, they were washed with PBS and trypsinised 
for one to three minutes - using 2001JI of 0.25% trypsin and 0.1% versene at 36°C -
and counted using a haemocytometer. At selected time points the cells were 
photographed after counting had been completed. A mean cell count at each time 
point was plotted and the population doubling time was determined for each cell type 
using the following formulae: 
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NO is the initial cell count and N1 is the subsequent cell count 
2.2.6 Osteogenic assay and bone detection 
To determine whether rMSCs and dermal clones OP9 and OS7 were capable of bone 
differentiation an osteogenic assay was performed. All cells were seeded out at a 
density of 3 000 cells/cm2 in six well plates (Nunc) in CCM and were allowed to 
become confluent. At confluence osteogenic differentiation was initiated in four of the 
six wells by switching the cells into osteogenic medium. The other two control wells 
were cultured in control medium consisting of CCM. Osteogenic medium was made 
up of control medium supplemented with 1 OOnM dexamethasone (Sigma-Aldrich), 
501JM ascorbic acid 2-phosphate (Sigma-Aldrich) and 1 OnM 13-glycerophosphate 
(Sigma-Aldrich). The medium was changed every three days and the cultures were 
maintained for three weeks. 
After three weeks the medium was removed, the cells were washed twice using PBS 
and fixed using 4% PFA for 15 minutes. The presence of bone nodules was detected 
using Von Kossa staining. For Von Kossa staining the cells were incubated in 5% 
silver nitrate (Sigma-Aldrich) solution protected form light, washed with two changes 
of distilled water and subjected to intense light for 15 minutes. Mineralised areas 
identified by Von Kossa staining were visualised using a phase contrast microscope. 
2.2. 7 Adipogenic assay and lipid detection I 
Prior to differentiation rMSCs and the dermal clones OS7 and OP9 were seeded in 
35mm diameter six well plates (Nunc) at a density of 2 x 104 cells/cm2 per well and left 
to adhere in CCM at 3TC and 5% C02. When the cells were confluent adipogenic 
differentiation was initiated using an induction/maintenance cycle, which was repeated 
until the cells had been cultured for three weeks. In detail each cycle consisted of 
three days in induction medium (CCM supplemented with 11JM dexamethasone, 
0.2mM indomethacin (Sigma-Aldrich), 1 O!Jg/ml insulin (Sigma-Aldrich), and 0.5mM 
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IBMX (Sigma-Aldrich) and two days in maintenance medium (CCM supplemented 
with 1 OJ,Jg/ml insulin). 
After three weeks the cells were fixed and intracellular lipid production was detected 
using the oil red-O assay. For fixation the cells were washed three times for five 
minutes in PBS, fixed with 4% PFA for 15 minutes at room temperature and washed 
again using PBS. The cells were then stained for 15 minutes with a filtered working 
solution of oil red-O, which contained 60% saturated oil red-O (RA Lamb) in 
isopropanol (Fisher) and 40% distilled water. Excess oil red-O was removed with 
three five minute washes of PBS and nuclei were stained for five minutes using 
hematoxylin solution (RA Lamb). The cells were washed three times in PBS and their 
nuclei were blued in water using 3% ammonia blueing solution. Lipids vacuoles were 
imaged using a microscope. 
2. 2. 8 Adipogenic assay and lipid detection II 
Differentiation of DS7 clone and MSCs was achieved using a second protocol 
previously outlined for the dermal clones [18]. In addition adipogenic potential of DS7 
was assessed at high passage (P31) and low passage (P22) number. Briefly, prior to 
differentiation cells were seeded in 35mm diameter six well plates at a density of 100 
000 cells per well and left to adhere overnight under proliferative conditions (10% FCS 
and MEM at 3TC and 5% C02. Four of the wells were then switched into adipogenic 
medium for one week whereas the other two remained in proliferative conditions for 
the same length of time. Adipogenic medium consisted of MEM supplemented with 
15% rabbit serum (Sigma-Aldrich), 100nM dexamethasone, 0.45mM of IBMX and 
2.07mM insulin. The medium was changed every three days and the cultures were 
maintained for one week. Control conditions consisted of MEM supplemented with 
10% FCS. 
After culture cells were fixed and stained to detect lipid formation using the oil red-O 
assay. Firstly the cells were washed using PBS and fixed in calcium formol (4% PFA 
and 1% calcium chloride (Fischer)) for 15 minutes at room temperature. 
Subsequently the cells were incubated in 60% isopropanol for 15 minutes and then 
stained for a further 15 minutes with a filtered working solution of oil red-O. After 
staining the cells were washed with 60% isopropanol for one minute and washed 
again three times for five minutes with distilled water. Lipids vacuoles were visualised 
using a microscope. 
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2.3 Aggregate and conditioned media studies 
2. 3. 1 Aggregate formation 
Induction of rMSCs and the two dermal clones DS7 and DP9 to form aggregates was 
achieved using established methods with adaptation [128]. Prior to induction cells 
were cultured in CCM. For induction CCM flasks for all cell types were trypsinised 
and resuspended to form a single cell suspension in aggregate induction medium. 
Aggregate induction medium consisted of DMEM:F12 (Invitrogen) medium 
supplemented with 1 x N-2 supplement (Invitrogen), 2mM L-Giutamine, 20 units/ml 
Penicillin-Streptomycin, 40ng/ml heparin (Sigma-Aldrich), 10ng/ml of EGF (Sigma-
Aldrich) and 1 Ong/ml bFGF (Invitrogen) at 3TC, 5% C02 and 4.9% 0 2. The cells 
were induced at a range of densities; 1 00 000 cells/cm2 for rMSCs, 160 000 - 320 
000 cells/cm2 for the DS7 clone and 128 000 - 256 000 cells/cm2 for DP9 clone in 
25cm2 adherent tissue culture flasks (Nunc) and 12 well plates. For rMSCs the 
medium was changed every three days and for the dermal clones the medium was 
changed after one day of culture and every three days subsequently. 
2. 3. 2 Aggregate expression profile 
For immunocytochemistry induced cells were fixed using 4% PFA as adherent 
aggregates in 12 well plates and tested for the intracellular antigens nestin, TuJ-1 and 
a-SMA using the procedure outlined in section 2.2.2. 
The rMSC aggregates and DS7 aggregates were analysed using flow cytometry for 
the intracellular antigens nestin and a-SMA. Free floating aggregates were removed 
with induction medium and pelleted at 250 X g, while adherent aggregates were 
washed with PBS. Both types of aggregate were incubated with 3ml of 0.25% trypsin 
and 0.1% versene at 36°C for five minutes in 35mm dishes (nunc) for free floating 
aggregates, and three minutes in the 25cm2 tissue culture flasks for adherent 
aggregates. After incubation the free floating aggregates were dissociated by 
trituration, whereas the adherent aggregates were dissociated by slapping the side of 
the tissue culture flask. Once a single cell suspension was achieved CCM was added 
to inactivate the trypsin. For comparison with the induced condition rMSCs and DS7 
clone were grown to confluency in CCM in 75cm2 tissue culture flasks and 
trypsisnised. After collecting the cells a procedure similar to the one used for cell 
surface antigen expression was followed (section 2.2.4) with the some adaptations. 
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Firstly, prior to incubation in intracellular primary antibodies, and after fixation in 
0.25% PFA, the PFA was removed with a wash of PBS and the cells were 
permeabilisated at 37°C for 30 minutes in 1ml of 0.2% Triton-X-100 dissolved in PBS 
at pH 7. 1 ml of wash buffer was added to the 0.2% Triton-X-100, the cells were spun 
at 250 X g, resuspended in wash buffer and 800 000 cells were dispensed in 2001-11 
volumes into 15m I tubes. For intracellular staining the wash buffer consisted of 1% 
goat serum (Sigma-Aldrich), 0.2% Tween-20 (Sigma-Aldrich) and 0.1% sodium azide 
dissolved in PBS. The primary and secondary antibodies were used at the same 
dilution as for immuncytochemistry. Finally thresholds that determined the frequency 
of positive cells were set using a negative control consisting of cells that had been 
incubated in the appropriate secondary antibody only, prior to analysing levels of 
tested cell surface antigens. 
2.3.3 Analysis of aggregate frequency and size 
To analyse the frequency of rMSC, DS7 and DP9 aggregates the three cell types 
were induced to form aggregates at three different passage numbers (section 2.3.1 ). 
When the aggregates first appeared 20 non-overlapping visual fields at four times 
magnification were taken for each passage number. The number of aggregates was 
counted in each visual field and the mean number of aggregates per visual field was 
calculated for each cell type. To analyse aggregate size 20 randomly selected non-
overlapping fields were taken of aggregates at each passage number at 20 times 
magnification immediately after they began to form. The analysis was repeated for 
three different passage numbers. The area of the aggregates was measured in 
micrometers using Image J software, and the mean area was calculated for the 
aggregates across all three passage numbers. 
2.3.4 Generation of conditioned media 
Once the aggregates had formed after induction of rMSCs and the dermal clones DS7 
and DP9, conditioned media was generated by culturing the aggregates in aggregate 
induction medium for three days at 37'C, 5% C02 and 4.9% 0 2. The aggregates were 
removed from the medium by centrifugation at 250 X g, the medium was filter 
sterilised into fresh 15ml tubes using 0.21-Jm filters (VWR) and stored at -20°C. 
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2.3.5 The effect of conditioned media on neural progenitor cell development 
Adult hippocampal progenitor cells (AHPCs) were kindly donated by Fred Gage (Salk 
Institute). Prior to treatment with conditioned media AHPCs were passaged once at a 
dilution of 1 :3 and expanded in 75cm2 tissue culture flasks coated overnight with poly-
L-ornithine (1 Oj.Jg/ml; Sigma-Aldrich) and mouse laminin (51Jg/ml; Sigma-Aldrich). 
Expansion medium consisted of high glucose DMEM:F12 (Irvine Scientific), 1 x N-2 
supplement, 2mM L-glutamine, 20 units/ml Penicillin-Streptomycin and 20ng/ml bFGF. 
The conditioned media from all three cell types was cultured with the AHPCs using an 
established procedure with adaptation [125]. Eight well glass culture slides (BD 
Falcon) were coated with poly-L-ornithine (501Jg/ml) and laminin (51Jg/ml). AHPCs 
were seeded onto the coated culture slides at a density of 1 0 000 cells/cm2 and 
allowed to adhere overnight in expansion medium at 5% C02 and 37°C. After 24 
hours the expansion medium was removed, conditioned media from each cell type 
was defrosted and added to the wells. Two controls were cultured alongside the 
conditioned media samples; the first was AHPCs cultured in expansion medium and 
the second was AHPCs cultured in fresh aggregate induction medium without EGF 
and bFGF. The medium in all three conditions was changed at three and six days 
and phase images were taken of the AHPCs at these time points. After seven days 
culture the cells were fixed using 4% PFA and tested for expression of the intracellular 
antigens nestin, TuJ-1, and GFAP (at the same dilutions as in section 2.2.2) and GaiC 
(Chemicon; 1 :200). The procedure used was very similar to that previously discussed 
for immuncytochemistry (section 2.4), except here Cy3 anti-mouse and anti-rabbit 
secondary antibodies (Jackson Immune Research laboratories) were used instead of 
FITC. The number of cells positive for each antigen and the total number of cells 
were then counted. The two counts were used to calculate the percentage of positive 
cells for each antigen. 
2.4 Data analysis 
2.4. 1 Image analysis 
Unless otherwise stated all labelled cells were visualised using a Nikon Diaphot 300 
inverted fluorescent microscope, and the images were captured using a Nikon DXM 
1200 camera with individual filters for each channel. Corresponding phase contrast 
images were obtained using the same microscope and other phase images were 
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gathered using an inverted Nickon 330 bright field microscope. Both colour and 
phase contrast images were adjusted using Adobe Photoshop software (Adobe 
systems, Mountain View, CA). 
2. 4. 2 Statistical analysis 
Statistical analysis was conducted by entering macros and equations into Microsoft 
excel. When the samples had homogenous variances and were normally distributed 
the parametric one-way Analysis of Variance (ANOVA) test was performed to check if 
differences between the means were significant. If a significant difference between 
the means was computed using the ANOVA test, then a post hoc Tukey test was 
performed to determine which means were significantly different from each other and 
which were not. When the sample variances were not homogeneous or the sample 
distribution was not normal then the non-parametric Kruskai-Wallis test was used to 
test if there were significant differences between the medians. If a significant 
difference was computed between the medians using the Kruskai-Wallis test, more 
than one Mann-Whitney U-test for unmatched samples was used - with the 
Bonferroni-Holm multistep correction - to determine which medians were significantly 
different. 
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CHAPTER 3: RESULTS 
3.1 Characterisation of cells 
3. 1. 1 Morphology and behaviour of rMSCs and the dermal clones 
The morphology of all three cell types changed notably during culture. After initially 
isolating rMSCs (PO) a number of spindle shaped cells (Figure 1A arrows) and tight 
round cells (Figure 1A arrow heads) were observed. After passage up to P2 much 
broader and flatter cells predominated in the cultures (Figure 1 E,F asterisks). During 
expansion to confluence it was apparent that rMSC cultures were dynamically 
changing between smaller rounder cells to large flat cells. Shortly after initially 
seeding the cells, the culture was dominated by smaller cells (Figure 2A, arrow), and 
after five days of culture the cells were larger and growing in colonies (Figure 2F, 
asterisk). Finally, at high confluence large flat cells dominated the culture (Figure 21, 
asterisk). The dermal clone DS7 showed considerable changes in morphology during 
expansion to confluence. At two days culture a large proportion of DS7 cells 
displayed a long and thin morphology (Figure 3A,B), whereas at high confluence after 
eleven days in culture the cells displayed a small, tight circular morphology (Figure 
3G,H). In contrast, the dermal clone DP9 showed a flattened fibroblast-like 
morphology at two days culture (Figure 4A,B), and expanded in colony-like clumps 
(Figure 4C,D), that increased in size to cover all the tissue culture plastic at 
confluence (Figure 4G,H). 
It has been observed that the dermal clones DS7 and DP9 would have required at 
least 16 population doublings to produce a confluent 35mm culture dish after their 
isolation, and that the majority of single cells failed to proliferate [18]. The corollary of 
this is the technique used to isolate both the dermal clones has selected for cells with 
significant proliferation capacities. This is reflected in the short population doubling 
times of 2.7 days for the P28 DS7 clone (Figure 58) and 2.5 days for the P28 DP9 
clone (Figure 5C). A much longer doubling time of 5.4 days for the P2 primary rMSCs 
(Figure SA) is more indicative of the slow cycling nature of stem cells in vivo. 
Alternatively slow cycling could indicate suboptimal culture conditions for the rMSCs 
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compared to the two dermal clones. The proliferation graphs are summarised in 
Table 4. 
3. 1.2 Chromosome counting and karyotype analysis 
Chromosome counting data for each of the cell types rMSCs, OS7 and OP9 is 
summarised in Table 1. Counting of metaphases in P4 rMSCs revealed they were 
close to diploid, however 46.66% of cells counted had more than the normal rat 
diploid chromosome number of 42. The average chromosome number was 42.3, with 
only 26.66% of rMSCs showing a normal number of chromosomes. Karyotyping of 
three metaphase cells revealed one normal rat karyotype (Figure 6F), one cell 
showing 43 chromosomes with a trisomy for chromosome nine (Figure 6G), and one 
cell with 44 chromosomes with trisomies for chromosomes eight and nine. The 
metaphase spreads of the P28 OS7 clone showed that these cells were polyploid 
(Figure 6A,B) and a detailed karyotypic analysis was not possible. The metaphase 
spread counts for P28 OP9 clone showed 53.33% of the cells analysed had the 
normal rat diploid chromosomes number of 42 and 33.33% of metaphases had only 
41 chromosomes. The rest of the cells counted had one more chromosome ( 13.33%) 
than the normal rat diploid number. One of the Karyograms revealed that one of the 
counts of 41 chromosomes was possibly due to a deletion of chromosome 14 (Figure 
60). 
3. 1.3 Intracellular antigen analysis 
Prior to analysis of the mesenchymal intracellular antigens vimentin, fibronectin and a-
SMA, rMSCs and the dermal clones OP9 and OS7 were expanded to confluence in 
CCM. The three mesenchymal markers were expressed in rMSCs (Figure 70 - F), 
which was supported by flow cytometry data (Table 2). The dermal clone OS7 also 
expressed the three mesenchymal markers (Figure 7 J - L) although the expression of 
a-SMA was heterogeneous, with some cells expressing the antigen more strongly 
then others. However, the differences in levels of expression were not large enough 
to show up as two distinct populations by flow cytometry (Table 2). Finally 
immunocytochemistry showed that OP9 was positive for the two mesenchymal 
markers fibronectin and a-SMA (Figure 7P - R) but only expressed vimentin at levels 
detectable by flow cytometry (Table 2). 
52 
Analysis of neural intracellular antigen expression in rMSCs and dermal clones DS7 
and DP9 was examined after expansion to confluence in CCM. Based purely on 
immunocytochemistry data both primary rMSCs and dermal clone DP9 were negative 
for the neural stem cell marker nestin, TuJ-1 and GFAP (Figure 7A- C & Figure 7M-
0). Seemingly contradictory evidence shown from flow cytometry readings indicated 
expression of these neural antigens in the dermal clone DP9 (Table 2). However, the 
mean fluorescence intensity (MFI) was low compared to other antigens that were 
detected by both immunocytochemistry and flow cytometry. Therefore, it can be 
concluded that the neural antigens were expressed at very low levels in the DP9 
clone, only detectable by flow cytometry. Conversely, nestin was detected by flow 
cytometry in rMSCs at MFI levels comparable to antigens detected by both 
techniques; however, only 0.35% of the cells expressed nestin (Table 2). 
Immunocytochemistry showed that both nestin and TuJ-1 were expressed in a small 
proportion of DS7 cells, whereas GFAP was not expressed (Figure 7G - 1). The dual 
population of nestin expressing cells was also clearly shown by flow cytometry with 
28.60% of cells expressing nestin at a high MFI (377.74). However, a dual population 
was not demonstrated by flow cytometry for the neuronal antigen TuJ-1; instead 
93.46% of cells expressed the antigen at a low MFI (31.39). The correlation between 
nestin expressing cells in the dermal clone DS7 and morphology was investigated 
further. These data showed there was no correlation between morphology and nestin 
expression, because nestin was expressed in a wide variety of cellular morphologies 
in DS7 cells. Examples included small round cells (Figure BA,B asterisks), large flat 
cells (Figure BC,D and Figure BG,H arrows), and bipolar cells (Figure BE,F and Figure 
BG,H arrow heads). 
The expression of the hair follicle dermal sheath and papilla marker Versican was 
investigated in all three cell types. Versican was shown to be specific to both 
components of the follicle dermis (Hoechst 33342 and fluorescence) and not the 
follicle root sheath (Hoechst 33342 only) of early anagen rat vibrissae follicles (Figure 
9A- C). The follicle dermal clones DS7 and DP9 both expressed versican (Figure 
9E,F) and the primary rMSCs of bone marrow origin did not (Figure 90). 
3. 1.4 Cell surface antigen analysis 
Haematopoietic and mesenchymal cell surface markers were used to measure 
similarity between the two dermal clones DS7 and DP9 and rMSCs. The cells were 
grown to confluence in CCM and analysed using flow cytometry. Haematopoietic 
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markers CD45 and CD34 were negative in rMSCs and both dermal clones DS7 and 
DP9. In contrast, mesenchymal markers CD44 and CD90 were expressed in all three 
cell types (Figure 1 0). The more specific mesenchymal marker, CD1 05, was not 
expressed in the dermal clones but was expressed in rMSCs (Figure 1 0). Hence by 
comparison with rMSCs it can be concluded that the dermal clones DS7 and DP9 
show some homologies with the mesenchymal cell surface phenotype (summarised in 
Table 3). However, it must be noted that these markers do not definitively define 
MSCs as, for example, CD44 is also expressed in epithelial cells [38]. 
Closer examination of CD44 expression in the dermal clone DS7 revealed two 
populations of cells expressing CD44 at different levels, which remain as the cells are 
proliferated. This is evidenced by flow cytometry histograms showing dual peaks 
between similar ranges of fluorescence intensities at two different passage numbers 
(Figure 11A,B). Furthermore, the frequency of the two CD44 positive populations of 
cells appeared to change as the cells were proliferated, indicating DS7 was constantly 
changing during expansion in culture. At P30 there is a similar cell count for each 
population indicated by the peaks being of a similar size (Figure 11A). However, at 
P41 there is a much higher frequency of cells at the lower fluorescence intensity peak 
compared to the higher intensity peak (Figure 11 B). These data suggest that as DS7 
is passaged either the cells expressing CD44 at a higher level are converted into 
those expressing CD44 at a lower level, or the cells expressing CD44 at a lower level 
become dominant in the culture, perhaps by a more rapid rate of proliferation. It can 
be concluded that as DS7 clone is passaged the expression of CD44 declines through 
the increase in proportion of cells expressing CD44 at a lower level. 
3. 1. 5 Potency of rMSCs and the dermal clones 
Unsurprisingly, osteogenic potential was detected in rMSCs by Von Kossa staining 
after three weeks induction in osteogenic medium (Figure 12A,B). However, it was 
clear that DS7 and DP9 were unable to form bone nodules over the same time period, 
as demonstrated by the lack of mineralisaton detected by Von Kossa staining (Figure 
12C- F). 
Using two different protocols rMSCs and the dermal clone DS7 were adipogenic. 
However, the dermal clone DP9 was not adipogenic using either protocol (Figure 13G 
- I). The first protocol (Figure 13 and Figure 14) involved growing the cells to 
confluence prior to differentiation and differentiating the cells in medium containing 
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DMEM and 10% FCS. The second protocol (Figure 15) involved seeding the cells at 
a lower density and differentiating them immediately in medium containing MEM, 15% 
rabbit serum, a 10 fold lower concentration of dexamethasone and without 
indomethacin. As expected P4 rMSCs were adipogenic using the first (Figure 13A -
C) and second protocols (Figure 15A - C), with slightly different lipid vacuole 
distributions within the cells. Adipogenic potential was shown in the dermal clone DS7 
as widely distributed (Figure 14A), high density oil red-O positive areas of cells (Figure 
13D,E and Figure 14E,G) using the first protocol, and intracellular accumulations of 
lipid vesicles using the second protocol (Figure 15D,E). The differing characteristics 
of the lipid vacuole accumulation could have been due to the two different protocols 
used. Using the second protocol, adipogenesis in DS7 declined as passage number 
was increased. At P20 the amounts of adipogenesis were low, with a small minority 
of oil red-O positive cells (Figure 150 - F), whereas at P33 no cells displayed 
adipogenic potential (Figure 15G - 1). In summary unlike bone marrow rMSCs the 
dermal clones showed limited capabilities of mesenchymal differentiation. Neither 
clone was osteogenic, and only the DS7 clone was adipogenic. 
3.2 Aggregates and conditioned media 
3.2.1 Aggregate formation 
Aggregate formation was possible in rMSCs and the dermal clones DS7 and DP9 
following transfer of the cells as a single cell suspension to inductive serum free 
medium supplemented with EGF (10ng/ml) and bFGF (10ng/ml) in 4.9% 0 2. However 
the seeding density of 100 000 cells/cm2 - used previously for human MSCs [128]-
was found to be suboptimal for aggregate formation in the dermal clones as the 
aggregates formed slowly over a period of several weeks (data not shown). Limited 
numbers of aggregates were yielded and the majority of cells remained as an 
adherent monolayer. When rMSCs were seeded for induction at 1 00 000 cells/cm2 in 
25cm2 tissue culture flasks a higher yield of free floating aggregates formed over a 
period of up to one week (Figure 16A,B). 
It was noted that a density of 100 000 cells/cm2 corresponded to a confluent 75cm2 
tissue culture flask of rMSCs when the cells were grown in CCM prior to induction. 
Therefore, to optimise the seeding density for aggregate formation in the two dermal 
clones DS7 and DP9, it was decided that the cells would be allowed to become 
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confluent in a 75cm2 tissue culture flask prior to induction. Once confluent the cells 
were seeded in 25cm2 flasks at densities corresponding to a confluent 75cm2 tissue 
culture flask and a half confluent 75cm2 tissue culture flask for comparison. This 
translated to seeding densities that ranged from 160 000 cells/cm2 (Figure 17 A- C) to 
320 000 cells/cm2 (data not shown) for the DS7 clone and 128 000 cells/cm2 (Figure 
18A) to 256 000 cells/cm2 (Figure 18B - D) for the DP9 clone. Both the higher and 
lower seeding densities showed an increased efficiency of aggregate formation in 
both types of dermal clone. The yield of aggregates was increased and the time 
taken for aggregate formation was decreased at the two seeding densities. 
Aggregates formed over a similar time period at both seeding densities with the higher 
of two densities producing a greater yield of aggregates. Hence, it was decided either 
seeding density could be used to generate aggregates in both the dermal cell types. 
At the optimised seeding densities rMSCs and the dermal clone DS7 were able to 
form aggregates in a similar fashion (Figure 16A,B & Figure 17A - C). Firstly 
aggregations of cells formed on the tissue culture ware, after 4-7 days these 
aggregations lifted off and became free floating spheres of variable morphology 
between cell types. The dermal clone DP9 formed aggregates over a much shorter 
time period of less than two days. The aggregates did not adhere to the tissue culture 
plastic, instead forming free floating aggregates after two days from the single cell 
suspension (Figure 18A - D). If the dermal clones DS7 and DP9 were left for more 
than one week then the free floating aggregates adhered to each other to form a 
larger structure of many aggregates. This observation was particularly prevalent in 
the DP9 clone, although the aggregates were easily dissociated from each other when 
the medium was changed. 
Aggregates were observed in primary rMSCs at passage numbers ranging from 
passage three to passage 10 (data not shown). However, at passage 10 mainly 
adherent aggregates were formed with a very few free floating cellular aggregates. 
Because of the high amount of expansion required in the isolation of the dermal 
clones DS7 and DP9 it was only possible to induce aggregates at a high passage 
number. Aggregates of the dermal clones DS7 and DP9 formed optimally at passage 
37 and passage 31 respectively. 
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3.2.2 Aggregate antigen expression profiles 
Aggregates for rMSCs and the dermal clones DS7 and DP9 were characterised in 
terms of their cell surface antigen expression, by both immunocytochemistry and flow 
cytometry. All three types of aggregates when grown in inductive serum free 
conditions expressed the neural stem cell marker nestin. Both rMSCs and the dermal 
clone DP9 showed an increase in nestin expression, after they were transferred from 
growing as an adherent monolayer in high serum control conditions (Figure 7A,M), to 
serum free aggregate forming inductive conditions (Figure 16E and Figure 18E). 
However, the dermal clone DS7 expressed nestin in both control conditions (Figure 
7G) and inductive conditions (Figure 17F), which was confirmed by flow cytometry. In 
contrast to nestin, a significant reduction in a-SMA expression in DS7 was also shown 
by flow cytometry, which indicated a loss of mesodermal identity under the inductive 
conditions (Figure 17D,E). The rMSCs showed a similar reduction in a-SMA 
expression when transferred to inductive conditions; however - unlike DS7 - a 
concomitant increase in nestin expression was observed (Figure 16C,D). Unlike 
rMSCs and DS7, a-SMA expression in the dermal clone DP9 remained high after 
transfer from control conditions (Figure 7R) to inductive conditions (Figure 18F). 
Finally, rMSC aggregates showed an increase in the neuronal antigen TuJ-1 
expression (Figure 16F) compared to the control (Figure 78), whereas dermal clone 
aggregates DS7 and DP9 did not. Hence it can be concluded that under inductive 
conditions aggregates of all three cell types showed variable degrees of change in 
antigen expression. However, rMSC aggregates showed the most significant 
changes with upregulation of the neural stem cell marker nestin and the neuronal 
marker TuJ-1 and downregualation of the mesodermal antigen a-SMA, when 
compared to control conditions. 
3. 2. 3 Aggregate frequency and size 
Aggregates were compared in terms of their frequency and size by counting and 
measuring (summarised in Table 5). The differences between rMSC and DS7 
aggregates mean areas, and the mean areas of rMSC and DP9 aggregates, were 
statistically significant (p < 0.05). However, the difference in DS7 and DP9 aggregate 
mean areas were not statistically significant (p < 0.05). The mean aggregate 
frequencies of rMSCs and DS7, and DS7 and DP9 were significantly different (p < 
0.025). However, the difference in mean aggregate frequency between rMSC and 
DP9 aggregates were not statistically significant (p < 0.025). In summary the mean 
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area data indicated a divide between the aggregates of dermal clones and rMSC 
aggregates (Figure 19A), whereas the frequency data set aside the aggregates of the 
dermal clone DS7 from rMSC and DP9 aggregates (Figure 198). It is likely that 
different balances between proliferation and cell death of the DS7 and DP9 clone 
aggregates and rMSC aggregates (Figure 5A - C) explains the different sizes and 
frequencies of the aggregates formed. 
3. 2. 4 Reversible neural-like differentiation in dermal clone DS7 
Individual cells that were still adherent to the tissue culture plastic showed a neural-
like morphology (Figure 20A - C), and developed alongside DS7 aggregates (Figure 
200) after induction. The observation that the adherent cells switched from a 
neuronal-like morphology back to flat fibroblast cells following the addition of fresh 
induction medium (Figure 20E,F) could be explained in two different ways. It is 
possible the neuronal-like cells died and the small proportion of remaining fibroblast-
like cells proliferated and became dominant. Or the neuronal cells themselves 
reverted back to the fibroblast-like morphology. The mechanism by which the 
observations were occurring, could be demonstrated if photomicrographs were taken 
of the same cells before and after the medium change. 
3.2.5 The effect of conditioned media on AHPC development 
AHPCs were seeded at a density of 10 000 cells/cm2 , which produced a sub-confluent 
culture after the cells were allowed to adhere overnight (Figure 21A and Figure 22A). 
Control conditions consisted of aggregate induction medium without EGF and bFGF 
and AHPC proliferation medium containing bFGF. After three days culture the AHPCs 
had clearly proliferated under the control conditions (Figure 21 B,C) and at six days the 
cells were at a high density, maintained a circular morphology but showed very limited 
process elaboration (Figure 21 D,E}. 
After seven days culture the controls were fixed and analysed for lineage specific 
antigens (Figure 23A - H). When cultured under control conditions the AHPCs were 
positive for the neural stem cell marker nestin (Figure 23A,B) and the early neuronal 
antigen TuJ-1 (Figure 23C - D). With the aggregate induction control 100% of 
AHPCs were positive for nestin and 97% were positive for TuJ-1, whereas with the 
AHPC proliferation control 99% of AHPCs were positive for nestin and 97% were 
positive for TuJ-1 (Figure 25 and Table 6). Neither control condition increased 
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expression of the astrocyte marker GFAP (Figure 23E - F) and the oligodendrocyte 
antigen GaiC (Figure 23G - H), with 0% of AHPCs expressing the two antigens in 
each case (Figure 25 and Table 6). In conclusion the expression profile determined in 
the controls was typical of a neuroblast. 
AHPCs were cultured with conditioned media to determine its effect on their 
development. Conditioned media was generated by growing cellular spheres - from 
rMSCs and the dermal clones DS7 and DP9 - for three days in serum free medium 
supplemented with EGF and bFGF. AHPCs were seeded at 10 000 cells/cm2 prior to 
the addition of the conditioned media samples. By comparison of the 
photomicrographs at zero, three and six days treatment with conditioned media it is 
clear the AHPCs continue to proliferate throughout the time course (Figure 22A- G). 
However DP9 conditioned medium (DP9-CM) induced less proliferation between day 
three and day six compared to the DS7 and rMSC conditioned media samples (Figure 
22D,G). By comparing the phase images of the conditioned media samples (Figure 
22A- G) with the control conditions (Figure 21A- E) it can be concluded that there 
was more extensive process development in the AHPCs cultured with conditioned 
media. Using all three conditioned media samples the cells have adopted glial-like 
morphologies with limited secondary arborisation. The rMSC conditioned medium 
induced a distinct branching pattern emanating from the soma and astrocyte-like 
bipolar morphologies (Figure 22B, arrow and arrow head). The bipolar morphologies 
were also seen in AHPCs cultured with DS7 and DP9 conditioned media (Figure 
22C,D arrow heads). 
At seven days culture the AHPCs treated with conditioned media were fixed and 
analysed for the same lineage specific antigens as the controls. This analysis showed 
a loss of the neuroblast phenotype in AHPCs after treatment with conditioned media 
samples, evidenced by a dramatic decline in TuJ-1 expression in the conditioned 
media treatments compared to the control conditions. In the two controls 97% of 
AHPCs were positive for TuJ-1, whereas after treatment with rMSC and DS7 
conditioned media TuJ-1 expression declined to 0% (Figure 24D,E, Figure 25 and 
Table 6). In contrast to the changes in TuJ-1 expression, nestin expression in AHPCs 
remained almost identical to the control conditions when AHPCs were treated with 
rMSC and DS7 conditioned media. 100% of AHPCs treated with rMSC and DS7 
conditioned media expressed nestin (Figure 24A,B, Figure 25 and Table 6). AHPCs 
showed a slightly different response to DP9-CM compared to rMSC and DS7 
conditioned media. A less dramatic decline in TuJ-1 expression was evident as 38% 
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of AHPCs expressed TuJ-1, whereas there was a complete loss of nestin expression 
with 0% of AHPCs expressing nestin after treatment with DP9-CM (Figure 24F,C, 
Figure 25 and Table 6). 
As TuJ-1 expression declined a concomitant increase in expression of the astrocytic 
marker GFAP was found in a small proportion of AHPCs treated with rMSC 
conditioned medium (8% GFAP+), DS7 conditioned medium (DS7-CM; 2% GFAP+) 
and DP9-CM (12% GFAP+) (Figure 24G - I, Figure 25 and Table 6). However, no 
cells expressed the oligodendrocyte specific antigen Gale after treatment with 
conditioned media (Figure 24J- L, Figure 25 and Table 6). 
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3.3 Figures 
Figure 1: Isolation of rMSCs from the postnatal bone marrow of the 
femurs and tibias of 6 - 8 month old Wistar rats. Photomicrographs show 
isolated cells growing at PO (A & B), P1 (C & D) and P2 (E & F) . Five days 
after the cells were isolated (A) they showed distinct morphologies including 
ovoid (arrow heads) and bipolar (arrows). After seven days PO rMSCs 
became confluent and began to spread out (B). Once passaged rMSCs 
displayed a more flattened morphology (C) and grow in colonies (D). At P2 
rMSCs showed a larger and increasingly flattened morphology (asterisks in E 
and F). Scale bars : 100J.Im. 
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Figure 2: Phase photomicrographs showing the growth of P2 
rMSCs over 11 days in CCM. The cells were plated at a density of 
30 000 cells per well in 24 well plates and cultured for 11 days. 
Phase photomicrographs were taken at 10 and 20 times 
magnification after two days (A & B), three days (C & D), five days 
(E & F) and 11 days (G & H). After being photographed the cells 
were then trypsinsed and counted. Scale bars : 100J.1m. 
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Figure 3: Phase photomicrographs showing the growth of P28 
dermal clone DS7 over 11 days in CCM. The cells were plated at 
a density of 30 000 cells per well in 24 well plates and cultured for 
11 days. Phase photomicrographs were taken at 1 0 and 20 times 
magnification after two days (A & B), three days (C & D), five days 
(E & F) and 11 days (G & H). After being photographed the cells 
were then trypsinsed and counted. Scale bars : 100pm. 
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Figure 4: Phase photomicrographs showing the growth of P28 
dermal clone DP9 over 11 days in CCM. The cells were plated at 
a density of 30 000 cells per well in 24 well plates and cultured for 
11 days. Phase photomicrographs were taken at 10 and 20 times 
magnification after two days (A & B), three days (C & D), five days 
(E & F) and 11 days (G & H). After being photographed the cells 
were then trypsinsed and counted. Scale bars : 100J.lm. 
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Figure 5: Proliferation graphs showing 
the slower growth rate of P2 rMSCs 
compared to the P28 dermal clones DS7 
and DP9 over 11 days in CCM. All three 
cell types were plated at a density of 30 
000 cells per well in 24 well plates and 
counted in triplicate at one, two, three, five, 
seven, nine and 11 days. The graphs 
show the growth curves using the mean 
count ±SEM at each time point of rMSCs 
(A) , and the dermal clones DS7 (B) and 
DP9 (C). The population doubling time in 
days is indicated in the bottom right hand 
corner of each of the graphs. 
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Figure 6: Chromosome counting and detailed karyotype analysis 
showing abnormalities in the two dermal clones 057, DP9 and P4 
rMSCs. Metaphase chromosomes were karyotyped and counted by 
Chrombios GmbH. Only polyploid metaphases were observed in DS7 
clone (A & B) and therefore a detailed karyogram could not be 
produced. An example metaphase spread (C) and karyogram (D) are 
shown for the DP9 clone. The karyogram (D) is an example of a 
deletion at chromosome 14 that produced a count of 41 
chromosomes. Lastly the chromosomes of primary rMSCs were 
counted and karyotyped. The metaphase spread (E) illustrates how 
counts of rMSC chromosomes were produced . The karyogram (F) 
shows rMSCs with no abnormalities. However, abnormalities in rMSC 
karyotypes were detected and at least partially accounted for by 
trisomies, wh ich were observed on chromosome 9 of one of the 
karyograms (G). 
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Figure 7: Expression profile of both neural and mesenchymal antigens on primary P3 rMSCs and P25 057 and DP9 deraml clones cultured in CCM 
for 24 hours. The neural stem cell marker nestin the neuronal marker TuJ-1 and the astrocytic marker GFAP were tested on primary rMSCs (A- C), DS7 
clone (G - I} and DP9 clone (M - 0). The mesenchymal antigens vimentin, fibronectin and a-SMA were tested on primary rMSCs (D - F), DS7 clone (J - L) 
and DP9 clone (P - R). 
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Figure 8: The expression of nestin in the dermal clone DS7 grown in 
CCM at 20 000 cells/cm2 does not correlate to cellular morphology. 
Fluorescent photomicrographs show nestin expression (A, C, E & G) and 
their corresponding phase photomicrographs (B, D, F & H). Scale bar : 
100J1m. 
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Figure 9: The dermal clones 057 and DP9 express the 
dermal papilla specific antigen versican whereas rMSCs 
do not. Fluorescent photomicrographs A - C are 71Jm 
sections taken from early anagen rat hair follicles embedded 
in OCT, which were used as positive controls. Fluorescent 
photomircraphs D - F test expression of versican in rMSCs 
(D) and the dermal clones DS7 (E) and DP9 (F). 
Scale bar : 1 OOpm. 
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Figure 10: Expression of 
the cell surface 
mesenchymal antigens 
CD44 and CD90, but not 
haematopoietic cell 
surfaces antigens CD34 
and CD45 by rMSCs and 
the dermal clones DS7 
and DP9. Prior to analysis 
all cell types were grown in 
CCM until confluency was 
reached. For each antigen 
the black peaks represent 
detection of primary 
antibodies by FITC 
conjugated secondary 
antibodies and the white 
peaks are controls that 
account for non-specific 
secondary antibody binding 
to the P3X control. The y-
axis represents cell count 
and the x-axis fluorescence 
intensity. The percentages 
of positive cells are shown in 
the top right of each 
histogram. 
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Figure 11: The changing expression of the cell surface antigen CD44 in the 
dermal clone 057 at passage 30 and passage 41 in CCM. The two flow 
cytometry histograms show the pattern of CD44 expression at passage 30 (A) 
and passage 41 (B). The black peaks represent detection of populations 
expressing CD44 by FITC conjugated secondary antibodies and the white peaks 
are controls that account for non-specific secondary antibody binding to the P3X 
control. The y-axis represents cell count and the x-axis fluorescence intensity. 
The percentages of positive cells are shown in the top right of each histogram. 
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Figure 12: Primary rMSCs show osteogenic potential after 
three weeks treatment in osteogenic medium whereas 
dermal clones DS7 and DP9 do not. The extent of 
osteogenic differentiation was assessed by examm1ng 
deposition of calcium using the Von Kossa stain with 
haematoxylin and eosin counter staining, after treatment with 
osteogenic medium and control CCM. The left 
photomicrographs (A, C & E) are controls whereas the right 
photomicrographs (8, D & F) represent cells treated with 
osteogenic medium. The cell types are represented as follows; 
rMSCs (A & B), DS7 clone (C & D), and DP9 clone (E & F). 
(Scale bar : 100pm). 
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Figure 13: Primary rMSCs and the dermal clone 057 
show adipogenic potential after three weeks 
treatment in adipogenic medium, whereas the 
dermal clones DP9 does not. Adipogenic 
differentiation was assessed by examining intracellular 
accumulation of lipid droplets using the oil red-O assay 
on fixed cells, after treatment with adipogenic medium 
and control CCM. The right photomicrographs (C, F & I) 
are controls whereas the left photomicrographs 
represent cells treated with adipogenic medium at 10 
times magnification (A, D & G) and 20 times 
magnification (8, E & H). The cell types are represented 
as follows; rMSCs (A- C), DS7 clone (0- F), and DP9 
clone (G- 1). Scale bars : 100J.lm. 
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Figure 14: Detailed analysis of the adipogenic potential of 
the dermal clone DS7 after three weeks induction in 
adipogenic medium. Adipogenic differentiation was assessed 
by examining intracellular accumulation of lipid droplets using 
the oil red-O assay on fixed cells, after treatment with 
adipogenic medium and control CCM. The left 
photomicrographs (A, C, E & G) represent cells treated with 
adipogenic medium at four times (A) , 10 times (C), 20 times (E) 
and 40 times magnification. The right photomicrographs (8, D, 
F & H) represent controls at four times (B) , ten times (D), 20 
times (F) and 40 times (H) magnification. Scale bars : 100J.1m. 
74 
Figure 15: The adipogenic potential of the 
dermal clone 057 declines as passage 
number increases, after one week induction 
in adipogenic medium previously used for 
dermal cells. Adipogenic differentiation was 
assessed by examining intracellular 
accumulation of lipid droplets using the oil red-
O assay on fixed cells, after treatment with 
adipogenic medium and control medium 
consisting of 10% FCS in MEM. The left 
photomicrographs (A, 8 , 0 , E, G & H) are cells 
treated in adipogenic medium, whereas the 
right photomicrographs (C, F & I) are cells 
treated under control conditions. Cell types 
are represented by the following 
photomicrographs; A-Care P4 rMSCs, 0- F 
are P20 dermal clone OS? and G - I are P33 
dermal clone OS?. Scale bar : 1 OOJ1m. 
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Figure 16: Generation of P3 MSC cellular aggregates positive for neural 
antigens and negative for the mesodermal antigen a-SMA following 
transfer to inductive serum free medium supplemented with EGF 
(10ng/ml) and bFGF (10ng/ml). Photomicrographs show free floating MSC 
aggregates form after 7 days induction at a density of 1 00 000 cells/cm2 (A & 
B). Small adherent aggregates appeared after two days induction (A). At 7 
days some of the adherent aggregates detached and developed into free 
floating aggregates (B). Flow cytometric analysis of the neural stem cell 
marker nestin and the mesodermal marker a-SMA (C & D). Cells were 
cultured under standard (control) conditions until confluent (C) and inductive 
(induced) conditions (D) for 7 days. After culture the cells were trypsinised to 
produce a single cell suspension, fixed and labelled with antibodies directed 
against nestin and a-SMA. The black peaks represent detection of primary 
antibodies by FITC conjugated secondary antibodies and the white peaks are 
controls that account for non-specific secondary antibody binding. The y-axis 
represents cell count and the x-axis fluorescence intensity. The percentage of 
positive cells for each antigen is indicated on the individual histograms. 
Immunocytochemistry and corresponding phase images (insets) revealed the 
aggregate expression pattern of the neural stem cell marker nestin (E) and the 
neuronal marker TuJ-1 (F). Scale bars : 100Jlm. 
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Figure 17: Generation of P37 DS7 clone cellular aggregates positive for 
the neural stem cell antigen nestin following transfer to inductive serum 
free medium supplemented with EGF (10ng/ml) and bFGF (10ng/ml). 
Photomicrographs show free floating DS7 aggregates gradually form over a 
period of 7 days after induction at a density of 160 000 cells/cm2 (A- C). After 
one day induction cells adhered to the tissue culture plastic at a high density 
and displayed a rounded morphology (A). At 5 days adherent aggregates 
formed (8), which subsequently became detached and developed into free 
floating aggregates at 7 days (C). Flow cytometric analysis of the neural stem 
cell marker nestin and the mesodermal marker a-SMA (D& E). Cells were 
cultured under standard (control) conditions until confluent (D) and inductive 
(induced) conditions (E) for 7 days. After culture the cells were trypsinised to 
produce a single cell suspension, fixed and labelled with antibodies directed 
against nestin and a-SMA. The black peaks represent detection of primary 
antibodies by FITC conjugated secondary antibodies and the white peaks are 
controls that account for non-specific secondary antibody binding. The y-axis 
represents cell count and the x-axis fluorescence intensity. The percentage of 
positive cells for each antigen is indicated on the individual histograms. 
Immunocytochemistry and corresponding phase image (inset) revealed the 
aggregate expression pattern of the neural stem cell antigen (F) . Scale bars : 
100pm. 
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Figure 18: Generation of P31 DP9 clone cellular aggregates positive for 
the neural stem cell marker nestin and the mesodermal marker a-SMA 
following transfer to inductive serum free medium supplemented with 
EGF (10ng/ml) and bFGF (10ng/ml). The low magnification 
photomicrographs show DP9 is able to form aggregates after induction at 
densities of both 128 000 cells/cm2 (A) and 256 000 cells/cm2 (B). Higher 
magnification photomicrographs of the clone induced at 256 000 cells/em (C 
& D) show the vast majority of aggregates were free floating after one day in 
induction medium. Immunocytochemistry and corresponding phase images 
(insets) reveals the aggregate's expression profile for the neural stem cell 
marker nestin (E) and the mesodermal marker a-SMA (F). Scale bars : 
100JJm. 
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Figure 19: Aggregates formed by rMSCs and dermal clones DS7 
and DP9 showed differences in terms of their area and frequency, 
after induction in serum free medium supplemented with EGF 
(10ng/ml) and bFGF (10ng/ml). Mean ± SEM aggregate area (A) 
and frequency (B) were determined. The post hoc Tukey test 
determined that the difference in the mean areas of rMSC and DS7 
aggregates, and the mean areas of rMSC and DP9 aggregates, were 
statistically significant (* = p < 0.05). The difference in the areas of 
DS7 and DP9 aggregates were not statistically significant (p < 0.05). 
Aggregate frequency data was not compatible with the ANOVA test 
because the variances were not homogeneous even after transforming 
the data. The non-parametric Kruskai-Wallis test was used instead 
and showed there were statistically significant differences between the 
median frequencies of aggregates (p < 0.05). The Mann-Whitney U-
test with the Bonferroni-Holm multi-step correction, showed that the 
frequency of rMSC and DS7 aggregates, and DS7 and DP9 
aggregates were statistically significantly different (** = p < 0.025). 
The difference in mean aggregate frequency between rMSC and DP9 
aggregates were not statistically significant (p < 0.025). 
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Figure 20: Formation of reversible neural-like structures and aggregates 
in cultures of P33 057 following transfer to inductive serum free medium 
containing EGF (10ng/ml) and bFGF (10ng/ml). Changes in adherent cell 
morphology were shown after treatment with induction medium with the 
majority of cells adopting a neuronal-like morphology (A - C). Free floating 
aggregate formation (D) was seen alongside changes to adherent cells. The 
day after a medium change, adherent fibroblast-like cells became dominant 
once again (E & F). Scale bar : 100JJm. 
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Figure 21: Under the two control conditions AHPCs continued to 
proliferative and maintained a rounded morphology with minimal 
process development. AHPCs were seeded at 10 000 cells/cm 2 prior to 
the addition of the two control media samples (A) . The control consisting 
of aggregate induction medium without EGF (1 Ong/ml) and bFGF 
(1 Ong/ml) is represented by photomicrographs of AHPCs after three (B) 
and six (D) days' culture. The AHPC proliferation medium control is 
represented by photomicrographs of AHPCs after three (C) and six (E) 
days' culture. Scale bar: 50J.im. 
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Figure 22: Conditioned media obtained 
from cellular spheres of rMSCs and dermal 
clones 057 and DP9 induced process 
development in AHPCs. Conditioned media 
was generated by growing cellular spheres for 
three days in serum free medium 
supplemented with EGF ( 1 Ong/ml) and bFGF 
(10ng/mp. AHPCs were seeded at 10 000 
cells/em prior to the addition of the 
conditioned media samples (A). MSC-CM is 
represented by photomicrographs of AHPCs 
after three (B) and six (E) days' culture. DS7-
CM is shown in the photomicrographs of 
AHPCs after three (C) and six (F) days' 
culture. Finally, the effect of DP9-CM on 
AHPC development is shown after three (D) 
and six (G) days' culture. Scale bar : 50J1m. 
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Figure 23: Nestin and TuJ-1 expression are high in 
AHPCs after culture for seven days in the 
aggregate induction medium without EGF and 
bFGF control, and the AHPC proliferation control. 
The aggregate induction medium without EGF and 
bFGF control is represented by the fluorescent 
photomicrographs A, C, E and G. Whereas the AHPC 
proliferation control is shown in the fluorescent 
photomicrographs B, D, F and H. AHPCs were tested 
for nestin (A & B), TuJ-1 (C & D), GFAP (E & F) and 
GaiC (G & H) antigen expression after seven days 
culture under the two conditions. Scale bar : 100f..lm. 
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Figure 24: After seven days in MSC-CM and DS7-CM 
AHPCs express nestin at a high level and GFAP at a low 
level, whereas in DP9-CM a small proportion of AHPCs 
express TuJ-1 and GFAP but not nestin. Conditioned 
media samples are represented as follows; MSC-CM (A, D, G 
& J), DS7-CM (8, E, H & K) and DP9-CM (C, F, I & L). 
AHPCs were tested for nestin (A, B & C), TuJ-1 (0, E & F), 
GFAP (G, H & I) and Gate (J, K & L) antigen expression after 
seven days culture with the conditioned media samples. 
Scale bar : 100JJm. 
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Figure 25: Cell counts reveal that after seven days in MSC-CM, DS7-
CM and DP9-CM nestin, TuJ-1 and GFAP expression in AHPCs 
changes compared to the two controls. The bars represent the 
percentage of positive cells per field of view for the two controls (AIM-GF 
and PROIF) and the three conditioned media samples (MSC-CM, DS7-
CM and DP9-CM). Therefore, there were potentially five bars for each of 
the antigens nestin, TuJ-1, GFAP and GaiC. However, bars did not show 
on several occasions, where no AHPCs were positive for the antigen. No 
statistical tests were performed to determine whether conditions were 
significantly different as the experiment was not repeated. Abbreviations; 
AIM-GFS: the control aggregate induction medium without EGF and 
bFGF, PROLIF: the control AHPC expansion medium, 
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3.4 Summary tables 
Cell type rMSCs DS7 DP9 
Chromosome count % % % 
41 26.66 33.33 
42 26.66 53.33 
43 33.33 13.33 
44 13.33 
Polyploid 100 
Table 1: Summary of chromosome counting data showing an abnormal chromosome 
number in at least a proportion of each cell type. A total of 15 metaphase chromosomes 
were counted for rMSCs and the dermal clones DS7 and DP9 by Chrombios GmbH. 
Cell type rMSCs DS7 DP9 
Antigen %Positive MFI %Positive MFI %Positive MFI 
Nestin 0.35 212.82 28.60 377.74 7.07 17.99 
TuJ-1 4.83 47.54 93.46 31.39 97.99 30.99 
GFAP 11.08 16.36 0.44 29.47 96.47 48.07 
Vimentin 98.06 453.93 99.25 211.62 98.47 20.94 
Fibronectin 97.14 267.03 99.42 255.20 96.46 169.16 
a-SMA 96.26 380.46 96.93 73.94 98.73 339.76 
Table 2: Flow cytometry data showing percentage of positive cells alongside the mean 
fluorescence intensity (MFI), which when considered together agree with 
immunocytochemistry data. rMSCs and the dermal clones DS7 and DP9 were grown to 
confluency in CCMI fixed in PFAI permiabalised and tested for the following antigens; nestinl 
TuJ-1 I GFAPI vimentinl fibronectin and a-SMA. 
Cell type rMSCs DS7 DP9 
Antigen %Positive MFI %Positive MFI %Positive MFI 
CD34 1.32±0.67 30.91 2.42±1.57 14.46 0.95±0.95 12.38 
CD45 1.80±1.49 46.90 1.28±0.65 15.51 0.52±0.63 15.51 
CD44 92.97±3.12 151.43 93.62±3.66 228.10 91.52±4.29 164.32 
CD90 94.83±1.99 107.06 96.46±0.79 198.22 95.56±0.82 273.11 
CD105 87.62±1.29 107.22 28.83±1.23 55.85 1.40±1.08 130.56 
Table 3: Summary of cell surface antigen expression showing that like rMSCs dermal 
clones DS7 and DP9 express mesenchymal antigens but not haematopoietic antigens. 
The mean percentage of positive cells is shown for each antigen ± SEM alongside a typical 
MFI reading for the positive cells. rMSCs and the dermal clones DS7 and DP9 were grown to 
confluency in CCMI fixed in PFA and tested for the following cell surface antigens; CD341 
CD451 CD44 I CD90 and CD105. 
86 
Cell type rM5Cs 057 OP9 
Days Cell count (x1 03) Cell count (x1 03) Cell count (x103) 
1 24.7±3.2 24.8±2.1 25.0±2.5 
2 27.5±0.7 82.2±3.3 52.7±2.4 
3 36.0±4.1 223.7±18.3 99.3±4.2 
5 49.7±3.7 241.0±16.9 140.0±32.5 
7 78.8±2.1 237.2±26.9 188.2±10.5 
9 89.2±7.4 253.3±8.6 358.7±14.1 
11 90.0±2.0 319.2±17.4 400.0±19.4 
Table 4: The slower growth rate of rMSCs compared to the dermal clones DS7 and DP9 
over 11 days in CCM. All three cell types were plated at a density of 30 000 cells per well 
and counted at one, two, three, five, seven, nine and 11 days. The mean count ±5EM at each 
time point of rM5Cs and the dermal clones 057 and OP9 is represented. 
Cell type 
Aggregate area (~m) 
Aggregate frequency 
rM5Cs 
6132±806 
22.00±1.75 
057 
10516±854 
10.17±0.83 
OP9 
9255±822 
55.60±6.52 
Table 5: Aggregates formed by rMSCs and dermal clones DS7 and DP9 showed 
differences in their area and frequency after induction. Mean aggregate area ±5EM and 
frequency ±5EM are summarised. 
Condition AIM-GF PROLIF. M5C-CM 057-CM OP9-CM 
Anitgen %Positive %Positive %Positive %Positive %Positive 
Nestin 100 99 100 100 0 
TuJ-1 97 97 0 0 38 
GFAP 0 0 8 2 12 
Gale 0 0 0 0 0 
Table 6: Cell counts reveal that after seven days in MSC-CM, DS7-CM and DP9-CM 
nestin, TuJ-1 and GFAP expression in AHPCs changes compared to the two controls. 
These data represent the two controls (AIM-GF and PROIF) and the three conditioned media 
samples (M5C-CM, 057-CM and DP9-CM). 
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CHAPTER 4: DISCUSS~ON 
4.1 The relationship of HFSC clones to bone marrow MSCs 
The isolation of MSCs from a wide variety of tissues has been has been previously 
demonstrated. The first part of this study has determined the relationship of two hair 
follicle clones termed DS7 and DP9 to primary bone marrow derived MSCs. The two 
cell types were characterised in terms of their morphology, proliferation, expression of 
intracellular and cell surface antigens and differentiation potential into bone and fat. 
After isolation and ex vivo expansion, morphologies of MSCs from bone marrow have 
been described as heterogeneous, ranging from spindle shaped cells to large broad 
flat fibroblast-like cells [130]. These observations have also been documented in the 
bone marrow MSCs used in this study. At sub-confluence the DS7 clone resembled 
spindle shaped MSCs, whereas the DP9 clone was more like the large broad flat 
MSCs. Therefore the dermal clones represented the two contrasting subpopulations 
existing within bone marrow MSCs. The morphological change observed in both 
clones at confluence was probably due constraints put on the cells after reductions in 
the space available. Neither DS7 nor DP9 proliferation was similar to MSC 
proliferation; this was almost certainly due to the selective pressure for rapidly dividing 
cells put on the dermal cells during their isolation. Expression of the intracellular 
mesenchymal antigens vimentin, fibronectin and a-SMA has been used to define 
many populations of MSCs isolated from a variety of tissues. However, all three of 
these markers have rarely been used simultaneously; instead just one is usually 
tested [85]. Here all three intracellular antigens were tested and expressed by the two 
clones with the exception of vimentin in DP9. Versican is a proteoglycan that is 
strongly expressed in rodent and human anagen hair follicle dermal papillae [131]. Its 
expression in the hair follicle dermal clones DS7 and DP9 and absence from bone 
marrow rMSCs confirmed the respective origins of these three cell types. 
This study has defined the surface protein expression profile of hair follicle dermal 
clones DS7 and DP9. It has been demonstrated that the phenotype of hair follicle 
dermal clones is homologous to that of primary rMSCs derived from bone marrow, 
which suggests they may be related to MSCs. The hair follicle is vascularised, 
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therefore there is a possibility the dermal clones were derived from circulating 
haematopoietic progenitors. Further it is feasible the clones are related to 
endogenous hair follicle dermal cells capable of repopulating the mouse 
haematopoietic system [26]. Both dermal clones were negative for the 
haematopoietic cell surface antigen CD34. However, the reliability of CD34 in 
demonstrating the absence of haematopoietic progenitors is questionable, as bone 
marrow MSCs have been identified as positive [132] and negative [17] for CD34. 
Further, CD34 has been used as a pluripotency indicator in studies of stem cells from 
the hair follicle bulge [29]. Therefore a second haematopoietic antigen CD45 was 
tested alongside CD34 to provide confirmation of their phenotype. The absence of 
CD45 and CD34 expression provided strong evidence against a relationship with the 
haematopoietic populations associated with the hair follicle dermis and instead 
suggested a possible relationship to bone marrow MSCs. This relationship was 
reinforced by the DS7 and DP9 being positive for the mesenchymal antigens CD44 
and CD90. Expression of CD44 indicates a relationship to bone marrow MSCs 
because it is known to interfere with the development of haematopoietic stem cells 
[133]. However, the expression of CD44 and CD90 must be reinforced by the 
expression of many other cell surface antigens and an ability support haematopoiesis, 
for DS7 and DP9 to be undeniably classified as bone marrow derived MSCs [70). 
This is especially important since CD44 has also been reported as a marker of 
epithelial and neuronal precursors [38]. Further classification was attempted with the 
CD105 antigen, which is more specific to bone marrow derived MSCs [17]. However, 
DS7 and DP9 clones did not express the antigen CD1 05. The absence of CD1 05 
expression therefore suggests that the DS7 and DP9 clones were not derived from 
circulating MSCs, which originally resided in the bone marrow. 
All previous attempts to determine mesenchymal potential of adult stem cell 
populations have demonstrated differentiation towards at least two mesodermal 
lineages. The use of antigens to characterise stem cell populations have their 
limitations, such as the promiscuous specificity some markers have to the 
mesenchymal cell types previously outlined. Differentiation towards fat and bone 
mesenchymal lineages was therefore attempted here in DS7, DP9 and rMSCs. The 
rMSCs were able to differentiate into bone and fat using all protocols. Neither of the 
dermal clones was able to differentiate towards bone, whereas DS7 but not DP9 was 
able to differentiate into fat. The lack of bone differentiation potential in both dermal 
clones is not in line with a previous study on the mesenchymal potential of clonally 
derive bone marrow MSCs. In this previous study all but one of the 185 clones were 
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able to differentiate into at least the bone lineage, which suggests, unlike the follicle 
dermis cells, this was the basic capability of the vast majority of bone marrow derived 
MSCs [89]. In contrast, a second study showed an inability of bone differentiation in 
the majority of clones isolated from bone marrow MSCs, however, this could have 
been induced by genetic manipulations undertaken to immortalise the clones [90]. A 
large variation in fat differentiation protocols exists in the literature; therefore two fat 
protocols were attempted in this study, which showed fat differentiation was still 
restricted to DS7 and bone marrow MSCs. Fat differentiation was shown to decline in 
087 as passage number increased, which has been shown in studies involving 
cloned bone marrow MSCs [89] and MSCs from the pancreas [78]. 
4.2 The ability of adult stem cells to form aggregates 
The ability of bone marrow derived MSCs and dermal papilla derived progenitors to 
form neruosphere-like structures in vitro after treatment with EGF and bFGF 
supplemented serum free medium has already been well established [53, 128]. 
Therefore the aim of this study was initially to demonstrate the development of neural 
antigen positive aggregates from the two hair follicle stem cell clones DS7 and DP9. 
This was attempted using an induction protocol previously described for MSCs [128], 
and rMSCs derived from bone marrow were used as a positive control. Preliminary 
findings were encouraging because all three cell types were able to form aggregates. 
However some differences were observed in the manor by which the aggregates 
formed. The dermal clone DS7 was most similar to rMSCs because adherent 
aggregates formed first, which eventually lifted off the tissue culture plastic. By 
contrast - unlike rMSCs and DS7 - the dermal clone DP9 aggregates did not adhere, 
instead they formed in suspension similar to aggregates derived from the hair follicle 
dermis [57, 58]. However, DP9 aggregates were more similar to aggregates from 
rMSC compared to DS7 aggregates in terms of their frequency. 
The expression of nestin was found in aggregates from all three cell types, which is 
similar to previous findings for neural crest related stem cell populations derived from 
the skin dermis and MSCs from bone marrow [53, 58, 128]. A loss in mesenchymal 
identity, previously demonstrated in bone marrow derived cells induced to form 
aggregates [128], was shown in the dermal clone DS7 and rMSCs by a reduction in a-
SMA expression. Expression of a-SMA was maintained in the dermal clone DP9, 
indicating less progression towards the neural lineage. Flow cytometry data indicated 
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that the formation of aggregates in D87 did not increase nestin expression, because it 
stayed at similar levels after induction. In conclusion aggregates of the two dermal 
clones do not follow the same changes in gene expression as rM8C aggregates. 
The maintenance of nestin expression in D87 and a-8MA in DP9 suggests aggregate 
formation in the dermal clones is not driving changes in gene expression. However, 
the apparent increase in nestin expression in DP9 and decrease in a-8MA expression 
in D87 would suggest some differentiation, and that the maintenance of marker 
expression in the aggregates represents a more primitive phenotype compared to the 
aggregates of rM8Cs. Evidence has been presented that shows induction of nestin 
expression in aggregates as a result of growing M8Cs at very high densities in high 
serum conditions that does not usually induce nestin expression [134]. This 
demonstrates that neural markers can be induced solely as a result of high density 
culture, which could provide an explanation not only for the increase nestin expression 
in DP9 but also rM8Cs. However, the absence of increased nestin expression in D87 
aggregates suggests high density culture is not the only factor important in inducing 
nestin expression. Neuronal differentiation was demonstrated in aggregates from the 
high density cultures [134]. Differentiation of these neural antigen positive aggregates 
was not as rigorously characterised as neural differentiation in aggregates derived 
from skin and bone marrow M8Cs [28, 57, 128]. Despite this the study still 
demonstrates that high density culture can induce the formation of primitive neural 
progenitors. Neural differentiation was not attempted here after the high density 
induction of the dermal clones to form aggregates, therefore these aggregates may 
not represent neural progenitors, and their formation could be largely due to an 
artefact created by high density cell culture. Furthermore, the use of nestin as a 
marker of neural stem cell-like aggregates is unreliable as nestin is known to be 
expressed in other non-neural stem cell tissues such as skeletal muscle [104]. 
Therefore in the case of DP9 and rM8C aggregates nestin expression indicates in 
vitro differentiation that is not necessarily indicative of N8Cs. A large number of 
neural markers would be needed to examine if these aggregates have true similarities 
to N8Cs. This study indcates that MSC aggregates more closely represent N8Cs as 
they express the neuronal marker TuJ-1 , whereas the 087 and DP9 dermal clone 
aggregates do not. Another piece of evidence that suggested neural development 
was an artefact of the culture conditions was the reversibility of neural morphologies in 
the adherent D87 population after induction. The neural-like phenotypes in D87 could 
be the result of similar cytoskeletal collapse mechanisms involved in the development 
of neural-like cells after chemical induction of M8Cs. 
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4.3 The effect of conditioned media on AHPC development 
Aggregate conditioned medium from rMSCs and the dermal clones DS7 and DP9 
induced process elaboration and maintenance of proliferation in AHPCs. Conditioned 
media samples from rMSC and DS7 aggregates induced a large decline in TuJ-1 
expression but not nestin in AHPCs. In contrast DP9 aggregate conditioned medium 
induced a smaller decline in TuJ-1 expression and a large decline in nestin expression 
in AHPCs. Finally all three types of conditioned media induced a small proportion of 
AHPCs to acquire a GFAP+ astrocyte phenotype but not a Gale+ oligodendrocyte 
phenotype. 
These data provide further evidence that soluble factors produced by adult stem cells 
induced to form aggregates expressing nestin are able to alter the development of 
neural progenitor cell populations in vitro. In a previous study the effect of conditioned 
medium from MSCs induced to express nestin resulted in selective attenuation of 
apoptosis in astrocytic progenitors [126]. In the present study differentiation of 
AHPCs was probably produced by an instructive effect of the conditioned media on a 
subpopulation of the AHPCs positive for TuJ-1 and nestin. This resulted in a decline 
in expression of TuJ-1 in MSC-CM and DS7-CM and a decline in both nestin and TuJ-
1 expression in DP9-CM. The absence of GFAP positive cells in control conditions 
suggests the astrocytic phenotype was not produced by selective survival or 
proliferation of this subpopulation after treatment with conditioned media. Dual 
labelling of the TuJ-1 and nestin positive AHPCs with PI would determine if the 
conditioned media was producing significant levels of cell death in the AHPCs. If 
significant levels of cell death were observed, then astrocytic differentiation could 
have been induced by the conditioned media enabling survival and instruction of a 
small subpopulation of AHPCs capable of astrocytic differentiation. Without selective 
mechanisms, the phenotypes produced in AHPCs by the conditioned media were 
likely to be at a transitional stage between undifferentiated AHPC progenitors and 
more differentiated derivatives. 
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4.4 The limitations of in vitro cell culture 
Transformation of cell types in vitro is of considerable concern to stem cell biologist as 
transformed cells are no longer an accurate representation of their in vivo 
counterparts. To use adult stem cells for autologous treatment of degenerative 
diseases they need to be expanded in vitro to create a large enough number of cells. 
If adult stem cells undergo transformation in vitro then they cannot be safely returned 
the body in a cell replacement context. Transformation has been illustrated in this 
study by an abnormal karyotype in the dermal clones DS7 and DP9 and rMSCs. DS7 
showed a high degree of polyploidy whereas DP9 and rMSCs had fewer but 
nonetheless significant karyotypic irregularities. A number of phenotypic 
abnormalities suggestive of transformed cells were observed in DS7. For example 
differential expression intracellular antigens TuJ-1, nestin and a-SMA suggested the 
DS7 culture consisted of two distinct populations of cells. Furthermore changes to the 
expression of the cell surface antigen CD44 and loss of adipogenic potential at high 
passage numbers indicated DS7 was dynamically changing and adapting to the 
culture conditions. 
Senescence is a phenomenon which is common in adult stem cells and can be 
speeded up after in vitro expansion of MSCs (135, 136]. However, both the dermal 
clones showed no evidence of senescence, as the DS7 clone continued to proliferate 
at P41 and the DP9 clone at P32. Indeed the indefinite proliferation of human ES 
cells in vitro is thought to be the result of genetic abnormalities acquired in culture 
(137]. Hence, it is possible the karyotypic abnormalities in DS7 and DP9 have lead to 
their continued proliferation in vitro. De novo mutations can be established in vitro by 
enzymatic dissociation during passage, and variations in oxygen tension [138]. Extra 
copies of genes evident in the polyploid DS7 could have enhanced proliferation due to 
expression of duplicated growth stimulating genes. Also karyotypic instability could 
cause aberrant expression of genes such as telomerase, which maintains telomere 
length and therefore allows cells to continue dividing (139]. 
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4.5 Concluding remarks 
This study has found homologies between clonally derived populations of HFSCs and 
bone marrow MSCs in terms of their mesenchymal capabilities. It has also 
demonstrated clonally derived HFSCs can form aggregates similar to those produced 
by MSCs, which produce soluble factors that induce an astrocytic phenotype in a 
small proportion of neural progenitor cells. Finally this study has underlined the 
limitations of expanding adult stem cells ex vivo, and highlighted that we must review 
the techniques used to expand adult stem cells if they are to be used for tissue 
replacement therapies. 
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